| scholarly article | Q13442814 |
| P2093 | author name string | H J BLOOM | |
| W W RICHARDSON | |||
| P2860 | cites work | Biopsy of the breast followed by delayed radical mastectomy | Q74274251 |
| The problem of prognosis in cancer of the breast | Q78605198 | ||
| Survival in breast cancer cases in relation to the structure of the primary tumor and regional lymph nodes | Q78662075 | ||
| Carcinoma of the breast in the pregnant and the nursing patient; review of 1,375 cases | Q35529657 | ||
| The significance of early diagnosis in breast cancer: a study of some common usages of the term | Q36036436 | ||
| Sinus histiocytosis: a fallacious measure of host resistance to cancer. | Q54736071 | ||
| Some prognostic factors, particularly biopsy, in carcinoma of the breast | Q73149463 | ||
| Pathology of primary and recurrent carcinoma of the human breast after administration of steroid hormones | Q73176632 | ||
| Steroid hormone therapy in mammary carcinoma | Q74032741 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | breast cancer | Q128581 |
| P304 | page(s) | 359-77 | |
| P577 | publication date | 1957-09-01 | |
| P1433 | published in | British Journal of Cancer | Q326309 |
| P1476 | title | Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years | |
| P478 | volume | 11 |
| Q28568948 | 17Beta-hydroxysteroid dehydrogenase type 1 and type 2 in human breast carcinoma: a correlation to clinicopathological parameters |
| Q33982906 | A Brief History of Breast Cancer: Part II - Evolution of surgical pathology |
| Q88341477 | A Point-based Histologic Scoring System for Hepatocellular Carcinoma Can Stratify Risk of Posttransplant Tumor Recurrence |
| Q58423595 | A Practical Approach to the Use of Immunohistochemistry in the Diagnosis and Management of Breast Disease |
| Q72916416 | A Two-Stage Immmunocytochemical Method for Oestrogen Receptor Analysis: Correlation with Morphological Parameters of Breast Carcinomas |
| Q36216799 | A combination of green tea extract, specific nutrient mixture and quercetin: An effective intervention treatment for the regression of N-methyl-N-nitrosourea (MNU)-induced mammary tumors in Wistar rats |
| Q81412674 | A comparative analysis of core needle biopsy and fine-needle aspiration cytology in the evaluation of palpable and mammographically detected suspicious breast lesions |
| Q41176931 | A comparative study of histopathology, hormone receptors, peanut lectin binding, Ki-67 immunostaining, and nucleolar organizer region-associated proteins in human breast cancer |
| Q36648545 | A comparison of rapid methods including imprint cytodiagnosis for the diagnosis of breast tumours |
| Q36645502 | A comparison of two methods of prognostic typing in breast cancer |
| Q67443434 | A correlation of DNCB-induced delayed cutaneous hypersensitivity reactions and the course of disease in patients with recurrent breast cancer |
| Q70823134 | A flow cytometric study of c-erbB-3 expression in breast cancer |
| Q36990777 | A microscopic landscape of the invasive breast cancer genome |
| Q33773010 | A model of immunohistochemical differences between invasive breast cancers and DCIS lesions tested on a consecutive case series of 1248 patients |
| Q70166869 | A morphometric expression of differentiation in fine-needle biopsies of breast cancer |
| Q42755933 | A new cell line (8701-BC) from primary ductal infiltrating carcinoma of human breast |
| Q36738659 | A new histological therapeutic classification system to predict eradicated and residual lymph nodes in breast cancer after neoadjuvant chemotherapy |
| Q46474564 | A note from history: Landmarks in history of cancer, Part 6. |
| Q69567089 | A paradigm for oncogene complementation in human breast cancer |
| Q43125088 | A polarization-sensitive light field imager for multi-channel angular spectroscopy of light scattering in biological tissues |
| Q44413161 | A population-based study on variations in the use of adjuvant systemic therapy on postmenopausal patients with early stage breast cancer |
| Q36135222 | A predictive index of axillary nodal involvement in operable breast cancer |
| Q36694138 | A prognostic index for operable, node-negative breast cancer. |
| Q36046176 | A prognostic index in primary breast cancer |
| Q35981362 | A prognostic score in histological node negative breast cancer |
| Q55301938 | A proposal for a new histological classification scheme for predicting short-term tumor recurrence and death in patients with invasive ductal carcinoma of the breast. |
| Q71789829 | A prospective analysis of immunohistochemically determined hormone receptors and nuclear features as predictors of early recurrence in primary breast cancer |
| Q52079134 | A quantitative model using mean and standard deviation for evaluation of interobserver agreement in nuclear atypia scoring of breast carcinomas in a protocol study. |
| Q35687586 | A retrospective analysis of breast cancer subtype based on ER/PR and HER2 status in Ghanaian patients at the Korle Bu Teaching Hospital, Ghana |
| Q43488390 | A retrospective cohort study of Histologic risk factors in breast cancer patients |
| Q33673226 | A scoring system to predict breast cancer mortality at 5 and 10 years |
| Q41247381 | A second trefoil protein, ITF/hP1.B, is transcribed in human breast cancer |
| Q24685409 | A sequence previously identified as metastasis-related encodes an acidic ribosomal phosphoprotein, P2 |
| Q77889665 | A simple index using video image analysis to predict disease outcome in primary breast cancer |
| Q36002094 | A single institution experience with skin sparing mastectomy and immediate breast reconstruction |
| Q52703266 | A statistical approach to an individualized prognostic index (IPI) for breast cancer survivability. |
| Q42460625 | A study of high-nuclear-grade breast cancer in Thailand: subclassification and correlation with prognostic factors and immunohistochemical study |
| Q44178439 | A subset of breast invasive ductal carcinoma with distinctive cytomorphology, aggressive clinical behavior, and unique immunologic profiles |
| Q45932579 | A validated gene expression profile for detecting clinical outcome in breast cancer using artificial neural networks. |
| Q40171629 | A20/TNFAIP3, a new estrogen-regulated gene that confers tamoxifen resistance in breast cancer cells. |
| Q74082926 | Aberrant expression of cell-cycle regulator cyclin D1 in breast cancer is related to chromosomal genomic instability |
| Q36977572 | Aberrant methylation of the Adenomatous Polyposis Coli (APC) gene promoter is associated with the inflammatory breast cancer phenotype |
| Q35632602 | Aberrantly expressed mRNAs and long non-coding RNAs in patients with invasive ductal breast carcinoma: a pilot study |
| Q50761940 | Abnormal chromosome 8 copy number in cytological smears from breast carcinomas detected by means of fluorescence in situ hybridization (FISH). |
| Q38469406 | Abnormal chromosome 8 copy number in stage I to stage IV breast cancer studied by fluorescence in situ hybridization |
| Q67565699 | Abnormal p53 immunoreactivity and prognosis in node-negative breast carcinomas with long-term follow-up |
| Q37697240 | Accelerated whole breast irradiation in early breast cancer patients with adverse prognostic features |
| Q44963225 | Accuracy of axillary staging using sentinel node biopsy or diagnostic axillary lymph node dissection--a case-control study |
| Q47995096 | Activated lymphocytes from breast cancer patients express the characteristics of type 2 helper cells--a possible role for breast cancer-associated p43. |
| Q55313089 | Adhesion in Physiological, Benign and Malignant Proliferative States of the Endometrium: Microenvironment and the Clinical Big Picture. |
| Q34033287 | Adjuvant radiotherapy in breast cancer--the treatment of lymph node areas. |
| Q34385424 | Adjuvant treatment in node-negative, postmenopausal breast cancer |
| Q72428556 | Adjuvant treatment with polyadenylic-polyuridylic acid (Polya.Polyu) in operable breast cancer |
| Q27001994 | Advances in the Molecular Analysis of Breast Cancer: Pathway Toward Personalized Medicine |
| Q40312401 | Advances in the management of breast cancer: physician and surgeon |
| Q35887894 | African-American/White differences in breast carcinoma: p53 alterations and other tumor characteristics |
| Q47331126 | AgNORs and their relationship to cell size, histological grade, lymph node involvement, metastases, and survival pattern in carcinoma of the breast: a study from south India |
| Q34551314 | Age-linked prognostic categorization based on a new histologic grading system of neuroblastomas. A clinicopathologic study of 211 cases from the Pediatric Oncology Group |
| Q43191505 | Aggressiveness of 'true' interval invasive ductal carcinomas of the breast in postmenopausal women |
| Q43622146 | Alpha-tocopherol and hydroperoxide content in breast adipose tissue from patients with breast tumors |
| Q45064398 | Alteration of steroid hormone sensitivity during the cultivation of human mammary carcinoma cells |
| Q64891028 | Alterations in Copy Number of c-erbB-2 and c-myc Proto-oncogenes in Advanced Stage of Human Breast Cancer |
| Q36438383 | Alterations of p16-pRb pathway and chromosome locus 9p21-22 in sporadic invasive breast carcinomas. |
| Q36225128 | Altered expression pattern of integrin alphavbeta3 correlates with actin cytoskeleton in primary cultures of human breast cancer |
| Q77335768 | Amplification of c-myc gene and overexpression of c-Myc protein in breast cancer and adjacent non-neoplastic tissue |
| Q36187733 | An "elite hacker": breast tumors exploit the normal microenvironment program to instruct their progression and biological diversity |
| Q43997338 | An evaluation of predictive factors involved in clinical or pathological response to primary chemotherapy in advanced breast cancer |
| Q36081093 | An evaluation of preoperative CA 15-3 measurement in primary breast carcinoma |
| Q52420991 | An expert system for histological typing and grading of invasive breast cancer. First set up. |
| Q36466681 | An immunohistochemical evaluation of c-erbB-2 expression in human breast carcinoma |
| Q36028087 | Analyses of protein extracts of human breast cancers: changes in glycoprotein content linked to the malignant phenotype |
| Q37593925 | Analysis of molecular markers as predictive factors of lymph node involvement in breast carcinoma. |
| Q54360200 | Analysis of peptidyl-propyl-cis/trans isomerase 1 (PIN1) gene -842(G > C) and -667(T > C) polymorphic variants in relation to breast cancer risk and clinico-pathological parameters. |
| Q36620650 | Analysis of potential markers for detection of submicroscopic lymph node metastases in breast cancer |
| Q33847541 | Analysis of reproducibility of subjective grading systems for breast carcinoma |
| Q39739841 | Analysis of sentinel node biopsy - a single-institution experience supporting the use of serial sectioning and immunohistochemistry for detection of micrometastases by comparing four different histopathological laboratory protocols |
| Q43872377 | Analysis of the cytosolic content of the pS2 protein in breast cancer |
| Q68452405 | Analysis of the tumour-associated antigen TAG-12 by monoclonal antibody 7A9 in normal, benign and malignant mammary tissues |
| Q77882724 | Analyzing prognostic factors in breast cancer using a multistate model |
| Q44170719 | Aneuploid subpopulations in tumour-invaded lymph nodes from breast cancer patients |
| Q73834258 | Angiogenesis and blood vessel invasion as prognostic indicators for node-negative breast cancer |
| Q36614929 | Angiogenesis and hypoxia in lymph node metastases is predicted by the angiogenesis and hypoxia in the primary tumour in patients with breast cancer |
| Q54183910 | Angiogenesis as a predictor of long-term survival for 377 Japanese patients with breast cancer. |
| Q93641213 | Anti-estrogen treatment of postmenopausal breast cancer patients with high risk of recurrence: 72 months of life-table analysis and steroid hormone receptor status |
| Q43274816 | Anti-p53 antibodies in serum: relationship to tumor biology and prognosis of breast cancer patients |
| Q70267896 | Antiestrogen treatment of postmenopausal women with primary high risk breast cancer |
| Q35836033 | Apocrine carcinoma of the breast. A morphologic and immunocytochemical study |
| Q77371073 | Apoptosis and cell proliferation in medullary carcinoma of the breast: a comparative study between medullary and non-medullary carcinoma using the TUNEL method and immunohistochemistry |
| Q36620717 | Application of an original RT-PCR-ELISA multiplex assay for MDR1 and MRP, along with p53 determination in node-positive breast cancer patients |
| Q39961927 | Application of cryobiopsy to morphological and immunohistochemical analyses of xenografted human lung cancer tissues and functional blood vessels |
| Q77333227 | Applying the Nottingham Prognostic Index to a Swedish breast cancer population. South East Swedish Breast Cancer Study Group |
| Q36287924 | Are lower rates of surgery amongst older women with breast cancer in the UK explained by co-morbidity? |
| Q38487782 | Argyrophylic nucleolar organiser regions (AgNOR's) as a prognostic indicator in breast carcinoma |
| Q36034197 | Aspects of molecular phenotype and its correlations with breast cancer behaviour and taxonomy |
| Q50055724 | Assessing Risk Category of Breast Cancer by Ultrasound Imaging Characteristics |
| Q46103337 | Assessment of a rapid clearance blood pool MR contrast medium (P792) for assays of microvascular characteristics in experimental breast tumors with correlations to histopathology. |
| Q68585698 | Assessment of nucleolar organizer regions by automatic image analysis in breast cancer: correlation with DNA content, proliferation rate, receptor status and histopathological grading |
| Q73204435 | Assessment of proliferative activity in breast cancer: MIB-1 immunohistochemistry versus mitotic figure count |
| Q39436084 | Associated expressions of FGFR-2 and FGFR-3: from mouse mammary gland physiology to human breast cancer |
| Q39089837 | Association of L55M and Q192R polymorphisms in paraoxonase 1 (PON1) gene with breast cancer risk and their clinical significance. |
| Q89458033 | Association of Omentin-1 with Oxidative Stress and Clinical Significances in Patients with Breast Cancer |
| Q48624908 | Association of c-erbB-2 protein over-expression with high rate of cell proliferation, increased risk of visceral metastasis and poor long-term survival in breast cancer |
| Q72523273 | Association of immunohistochemical p53 tumor suppressor gene protein overexpression with prognosis in highly proliferative human mammary adenocarcinomas |
| Q43785936 | Association of increased lytic effector cell function with high estrogen receptor levels in tumor-bearing patients with breast cancer |
| Q41170688 | Augmented expression of Polo-like kinase 1 is a strong predictor of shorter cancer-specific overall survival in early stage breast cancer at 15-year follow-up. |
| Q41912803 | Automated and quantitative immunocytochemical assays of Bcl-2 protein in breast carcinomas |
| Q48501706 | Automated and quantitative immunocytochemical assays of CD44v6 in breast carcinomas |
| Q37006039 | Automated mitosis detection in histopathology using morphological and multi-channel statistics features. |
| Q36919089 | Automated mitosis detection using texture, SIFT features and HMAX biologically inspired approach. |
| Q33686269 | Axillary lymph node involvement in stage III breast cancer: treatment implications |
| Q30699989 | BAG-i expression in human breast cancer: interrelationship between BAG-1 RNA, protein, HSC70 expression and clinico-pathological data. |
| Q40910377 | Back to Basics: Traditional Nottingham Grade Mitotic Counts Alone are Significant in Predicting Survival in Invasive Breast Carcinoma. |
| Q53413635 | Balance of cell proliferation and apoptosis in breast carcinogenesis. |
| Q34331734 | Baseline tumor oxygen saturation correlates with a pathologic complete response in breast cancer patients undergoing neoadjuvant chemotherapy |
| Q39116598 | Bcl-2 expression and triple negative profile in breast carcinoma. |
| Q69855963 | Beneficial effect of adjuvant tamoxifen therapy in primary breast cancer patients with high oestrogen receptor values |
| Q40171314 | Benefits and Risks of Mammography |
| Q40017599 | Bilateral breast cancer, clinical and pathological review |
| Q44019153 | Bilateral breast cancer: one disease or two? |
| Q36608197 | Binding of lectins to human mammary tumors: ultrastructural study |
| Q36466496 | Biochemical and immunological characterizations of antigens recognised by human monoclonal antibodies |
| Q35817316 | Biological grading of breast cancer using antibodies to proliferating cells and other markers |
| Q73316227 | Biomarkers for local recurrence after breast-conservation--a nested case-control study |
| Q74360445 | Blood vessel invasion as a predictor of long-term survival for Japanese patients with breast cancer |
| Q35069144 | Bone marrow micrometastasis in breast cancer |
| Q64239476 | BreCaHAD: a dataset for breast cancer histopathological annotation and diagnosis |
| Q36039743 | Breast Cancer Grading |
| Q33562901 | Breast Cancer Metastasis to the Axillary Lymph Nodes: Are Changes to the Lymph Node "Soil" Localized or Systemic? |
| Q91943800 | Breast Cancer in Turkey; An Analysis of 20.000 Patients with Breast Cancer |
| Q39015288 | Breast Cancers Found with Digital Breast Tomosynthesis: A Comparison of Pathology and Histologic Grade |
| Q83874148 | Breast Carcinoma |
| Q66971305 | Breast cancer and prostaglandins: A new approach to treatment |
| Q42446359 | Breast cancer classification according to immunohistochemical markers: clinicopathologic features and short-term survival analysis in a population-based study from the South of Switzerland |
| Q30245184 | Breast cancer classification and prognostication through diverse systems along with recent emerging findings in this respect; the dawn of new perspectives in the clinical applications |
| Q31037977 | Breast cancer genetic evolution: I. Data from cytogenetics and DNA content |
| Q81073399 | Breast cancer in Chinese women younger than age 40: are they different from their older counterparts? |
| Q35233475 | Breast cancer in Hong Kong, Southern China: the first population-based analysis of epidemiological characteristics, stage-specific, cancer-specific, and disease-free survival in breast cancer patients: 1997-2001. |
| Q39504136 | Breast cancer in women under 30 years of age. |
| Q69540787 | Breast cancer prognosis in three different racial groups in relation to steroid hormone receptor status |
| Q35975691 | Breast cancer prognosis is poor when total plasminogen activator activity is low |
| Q40861646 | Breast cancer prognostic significance of a single nucleotide polymorphism in the proximal androgen response element of the prostate specific antigen gene promoter |
| Q74494450 | Breast cancer progression is associated with a reduction in the diversity of sialylated and neutral oligosaccharides |
| Q35993769 | Breast cancer proliferation measured on cytological samples: a study by flow cytometry of S-phase fractions and BrdU incorporation |
| Q34613657 | Breast cancer research output, 1945-2008: a bibliometric and density-equalizing analysis |
| Q36467136 | Breast cancer, prostaglandins and patient survival |
| Q35991639 | Breast cancer: relationship between the size of the primary tumour and the probability of metastatic dissemination |
| Q39718443 | Breast carcinoma |
| Q71269050 | Breast carcinoma in women 35 years of age or younger |
| Q46513924 | Breast carcinoma malignancy grading by Bloom-Richardson system vs proliferation index: reproducibility of grade and advantages of proliferation index |
| Q54266047 | Breast carcinoma presenting as axillary metastases without evidence of a primary tumor. |
| Q35994250 | Breast screening, prognostic factors and survival – results from the Swedish two county study |
| Q36087655 | Breast-conserving therapy for palpable and nonpalpable breast cancer: can surgical residents do the job irrespective of experience? |
| Q72686777 | C-erbB-2 overexpression in primary breast cancer: independent prognostic factor in patients at high risk |
| Q24795406 | C-myc, not HER-2/neu, can predict recurrence and mortality of patients with node-negative breast cancer |
| Q92451438 | CACTUS: cancer image annotating, calibrating, testing, understanding and sharing in breast cancer histopathology |
| Q33755823 | CAG repeat length polymorphism in the androgen receptor gene and breast cancer risk: data on Indian women and survey from the world |
| Q35214342 | CD105 expression on CD34-negative spindle-shaped stromal cells of primary tumor is an unfavorable prognostic marker in early breast cancer patients |
| Q36671336 | CD1a-positive infiltrating-dendritic cell density and 5-year survival from human breast cancer |
| Q34590820 | CD3+, CD4+ & CD8+ tumour infiltrating lymphocytes (TILs) are predictors of favourable survival outcome in infiltrating ductal carcinoma of breast |
| Q71687606 | CD44 exon 6 expression as a possible early prognostic factor in primary node negative breast carcinoma |
| Q73613515 | CD44 isoforms with exon v6 and metastasis of primary N0M0 breast carcinomas |
| Q33235269 | CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer |
| Q72091225 | CDw75 Antigen Expression in Breast Lesions |
| Q44162694 | CEA and HMFG in hyperplastic and malignant lesions of the breast |
| Q36506467 | CYTOLOGICAL DIAGNOSIS OF BREAST TUMOURS BY THE IMPRINT METHOD. |
| Q41887192 | Can internal mammary chain treatment decrease the risk of death for patients with medial breast cancers and positive axillary lymph nodes? |
| Q67461300 | Cancer prognosis predicted by preoperative lymphocyte responsiveness in vitro |
| Q33679786 | Cancerous breast lesions on dynamic contrast-enhanced MR images: computerized characterization for image-based prognostic markers |
| Q33517544 | Carcinoma of the breast: measurement and the management of treatment. I. The value of the data. |
| Q35976766 | Cathepsin D in breast secretions from women with breast cancer |
| Q35832132 | Cathepsin D in invasive ductal NOS breast carcinoma as defined by immunohistochemistry. No correlation with survival at 5 years |
| Q41831484 | Cathepsin D: an independent prognostic factor for metastasis of breast cancer |
| Q59300753 | Cell kinetics and hormonal features in relation to pathological stage in breast cancer |
| Q47137649 | Cell-based immunotherapy in stage IIIA inflammatory breast cancer with declining innate immunity following successive chemotherapies: A case report |
| Q73471075 | Cells producing cathepsins D, B, and L in human breast carcinoma and their association with prognosis |
| Q74319997 | Cellular proliferation in breast ductal infiltrating carcinoma. Correlation with clinical and histopathological variables |
| Q42816853 | Centrosome hyperamplification in human cancer: chromosome instability induced by p53 mutation and/or Mdm2 overexpression. |
| Q54172912 | Changing pattern of some pathologic parameters of mammary carcinoma. |
| Q33840054 | Characterisation of adenoid cystic carcinoma of the breast by immunohistology |
| Q39230164 | Characterisation of benign lesions and carcinomas of the female breast in a sub-Saharan African population |
| Q35233421 | Characterizing the clustered microcalcifications on mammograms to predict the pathological classification and grading: a mathematical modeling approach |
| Q81139820 | Chemokine receptor CXCR4 expression in breast cancer as a potential predictive marker of isolated tumor cells in bone marrow |
| Q72483593 | Childhood cancer and pregnancy drugs |
| Q46486645 | Chromosomal alterations associated with the transition from in situ to invasive breast cancer |
| Q36114935 | Chromosome alterations in breast carcinomas: frequent involvement of DNA losses including chromosomes 4q and 21q |
| Q72071904 | Chromosome analysis of 20 breast carcinomas: Cytogenetic multiclonality and karyotypic‐pathologic correlations |
| Q53006794 | Circulating Her-2/neu extracellular domain in breast cancer patients-correlation with prognosis and clinicopathological parameters including steroid receptor, Her-2/neu receptor coexpression. |
| Q37082568 | Classical pathology and mutational load of breast cancer - integration of two worlds |
| Q36929466 | Clinical Significance of Serum IL-12 Level in Patients with Early Breast Carcinoma and Its Correlation with Other Tumor Markers |
| Q34328025 | Clinical and biological relevance of enhancer of zeste homolog 2 in triple-negative breast cancer |
| Q49818524 | Clinical and molecular characterization of BRCA-associated breast cancer: results from the DBCG. |
| Q33500269 | Clinical and pathological response to primary chemotherapy in operable breast cancer |
| Q34065927 | Clinical course and prognostic factors following bone recurrence from breast cancer |
| Q37869333 | Clinical implications of cancer self-seeding |
| Q38431284 | Clinical management of breast cancer heterogeneity |
| Q40387685 | Clinical relevance of breast cancer biology. |
| Q34611172 | Clinical significance of preoperative serum interleukin-6 and C-reactive protein level in breast cancer patients |
| Q46630811 | Clinical significance of the quantitative assessment of the cytosolic concentration of HER-2/neu protein in breast cancer by immunoenzymatic assay (ELISA). |
| Q36395223 | Clinically relevant morphological structures in breast cancer represent transcriptionally distinct tumor cell populations with varied degrees of epithelial-mesenchymal transition and CD44+CD24- stemness. |
| Q77726693 | Clinicopathologic analysis of microscopically invasive breast carcinoma |
| Q45007095 | Clinicopathologic features associated with long-term survival in node-negative breast cancer patients |
| Q36621164 | Clinicopathologic study associated with long-term survival in Japanese patients with node-negative breast cancer |
| Q54936726 | Clinicopathological characteristics of primary breast cancer in older geriatric women: a study of 39 Japanese patients over 80 years old. |
| Q44505402 | Clinicopathological significance of HER2/neu genetic heterogeneity in HER2/neu non-amplified invasive breast carcinomas and its concurrent axillary metastasis |
| Q44685495 | Clinicopathological significance of intratumoural variations in elastosis grades and the oestrogen receptor status of human breast carcinomas |
| Q44573101 | Clinicopathological significance of tissue homeostasis in Indian breast cancer |
| Q74290130 | Clinicopathological value of somatostatin type 2A and estrogen receptor immunoreactivity in human breast carcinoma |
| Q42490109 | Co-expression of cytokeratin and vimentin intermediate filament proteins in benign and neoplastic breast epithelium |
| Q40827270 | Co-expression of tenascin-C and vimentin in human breast cancer cells indicates phenotypic transdifferentiation during tumour progression: correlation with histopathological parameters, hormone receptors, and oncoproteins |
| Q28360883 | Codon 89 polymorphism in the human 5 alpha-reductase gene in primary breast cancer |
| Q30505170 | Coherent angular motion in the establishment of multicellular architecture of glandular tissues |
| Q74288201 | Color-coded and spectral Doppler flow in breast carcinomas--relationship with the tumor microvasculature |
| Q37716586 | Combined evaluation of the FAS cell surface death receptor and CD8+ tumor infiltrating lymphocytes as a prognostic biomarker in breast cancer |
| Q63184914 | Combined sequential approach in locally advanced breast cancer |
| Q87774517 | Combined use of ¹⁸F-FDG PET/CT and MRI for response monitoring of breast cancer during neoadjuvant chemotherapy |
| Q73743999 | Comedonecrosis is an unfavorable marker in node-negative invasive breast carcinoma |
| Q35811287 | Comparative assessment of proliferation and DNA content in breast carcinoma by image analysis and flow cytometry. |
| Q36685203 | Comparative expression of the psoriasin (S100A7) and S100C genes in breast carcinoma and co-localization to human chromosome 1q21-q22. |
| Q36044679 | Comparative functional histopathology of human breast carcinoma xenografts |
| Q39238427 | Comparative histological, histochemical, immunohistochemical and biochemical studies on oestrogen receptors, lectin receptors, and Barr bodies in human breast cancer |
| Q36145746 | Comparison of Clinicopathological Features and Treatment Results between Invasive Lobular Carcinoma and Ductal Carcinoma of the Breast |
| Q40399423 | Comparison of Monofractal, Multifractal and gray level Co-occurrence matrix algorithms in analysis of Breast tumor microscopic images for prognosis of distant metastasis risk |
| Q70595710 | Comparison of classic and quantitative prognostic factors in hormone receptor-positive and hormone receptor-negative female breast cancer |
| Q33838441 | Comparison of extent of disease and morphometric and DNA flow cytometric prognostic factors in invasive ductal breast cancer |
| Q47162071 | Comparison of immune microenvironments between primary tumors and brain metastases in patients with breast cancer |
| Q77579557 | Comparison of immunohistochemical and biochemical measurement of steroid receptors in primary breast cancer: evaluation of discordant findings |
| Q37484662 | Comparison of the characteristics of medullary breast carcinoma and invasive ductal carcinoma. |
| Q46083625 | Comparison of the prognostic value of genomic grade index, Ki67 expression and mitotic activity index in early node-positive breast cancer patients |
| Q78008575 | Computerised counting of tumour infiltrating lymphocytes in 90 breast cancer specimens |
| Q43435574 | Conservation of the breast using two different radiotherapy techniques: interim report of a clinical trial |
| Q36225210 | Conservative management of breast cancer in the elderly in a developing country |
| Q35133721 | Conservative treatment of breast cancer: experience of a Tunisian team |
| Q35837885 | Content-based image retrieval of digitized histopathology in boosted spectrally embedded spaces |
| Q67315863 | Contraceptive steroids and breast cancer |
| Q44705029 | Contralateral cancerous breast lesions in women with clinical invasive breast carcinoma |
| Q53403033 | Contralateral parenchymal enhancement on dynamic contrast-enhanced MRI reproduces as a biomarker of survival in ER-positive/HER2-negative breast cancer patients. |
| Q47763856 | Contribution of germline mutations in cancer predisposition genes to tumor etiology in young women diagnosed with invasive breast cancer |
| Q46094678 | Cooperative involvement of NFAT and SnoN mediates transforming growth factor-β (TGF-β) induced EMT in metastatic breast cancer (MDA-MB 231) cells |
| Q24803055 | Core biopsy as a tool in planning the management of invasive breast cancer |
| Q34631710 | Correlation between MIB-1 and other proliferation markers: clinical implications of the MIB-1 cutoff value |
| Q52745531 | Correlation between cytometric features and mitotic frequency in human breast carcinoma |
| Q68509900 | Correlation between laminin and type IV collagen distribution in breast carcinomas, and estrogen receptors expression, lymph node and vascular involvement |
| Q35008633 | Correlation of GREB1 mRNA with protein expression in breast cancer: validation of a novel GREB1 monoclonal antibody |
| Q67977735 | Correlation of aromatase activity with histological differentiation of breast cancer--a morphometric analysis |
| Q34261726 | Correlation of cell-cycle kinetics, hormone receptors, histopathology, and nodal status in human breast cancer |
| Q73554845 | Correlation of cyclin D1 MRNA levels with clinico-pathological parameters and clinical outcome in human breast carcinomas |
| Q52318983 | Correlation of growth fraction by Ki-67 and proliferating cell nuclear antigen (PCNA) immunohistochemistry with histopathological parameters and prognosis in primary breast carcinomas. |
| Q69126172 | Correlation of growth fraction by Ki-67 immunohistochemistry with histologic factors and hormone receptors in operable breast carcinoma |
| Q72875161 | Correlation of hormone receptors with pathological features in human breast cancer |
| Q69811771 | Correlation of immunocytochemically demonstrated estrogen receptor distribution and histopathologic features in primary breast cancer |
| Q33277852 | Correlation of levels and patterns of genomic instability with histological grading of invasive breast tumors |
| Q77995550 | Correlation of numerical and structural status of chromosome 16 with histological type and grade of non-invasive and invasive breast carcinomas |
| Q71273201 | Correlation of steroid hormone receptor levels with histological grading in human breast cancer |
| Q39497104 | Correlation of steroid receptors with histologic differentiation in mammary carcinoma. A Singapore experience |
| Q70470756 | Correlations of the receptor content and ultrastructure of breast cancer cells |
| Q68092018 | Corticotropin-releasing hormone, luteinizing hormone-releasing hormone, growth hormone-releasing hormone, and somatostatin-like immunoreactivities in biopsies from breast cancer patients |
| Q36135002 | Creatine kinase BB isoenzyme levels in tumour cytosols and survival of breast cancer patients |
| Q33840292 | Critical evaluation of monoclonal antibody staining in breast carcinoma |
| Q33687123 | Current breast cancer proliferative markers correlate variably based on decoupled duration of cell cycle phases |
| Q35981737 | Cyclic AMP binding proteins and prognosis in breast cancer |
| Q74649736 | Cyclin-D1 expression in node-positive (N+) and node-negative (N-) infiltrating human mammary carcinomas |
| Q68326016 | Cytogenetics, flow cytometry, cytophotometry and morphometry of 22 cases of primary breast carcinoma |
| Q37255237 | Cytokeratin intermediate filament expression in benign and malignant breast disease |
| Q81129345 | Cytologic features of ductal carcinoma in situ in fine-needle aspiration of the breast mirror the histopathologic growth pattern heterogeneity and grading |
| Q92275255 | Cytological Correlates of Axillary Nodal Involvement in Invasive Ductal Carcinoma of Breast |
| Q90053853 | Cytological Grading of Breast Tumors-The Human and Canine Perspective |
| Q50769182 | Cytological criteria for the diagnosis of intraductal hyperplasia, ductal carcinoma in situ, and invasive carcinoma of the breast. |
| Q37742074 | Cytological vs histological evaluation of percutaneous biopsies |
| Q79079235 | Cytopathological grading, as a predictor of histopathological grade, in ductal carcinoma (NOS) of breast, on air‐dried Diff‐Quik smears |
| Q59652154 | Cytoplasmic CXCR4 expression in breast cancer: induction by nitric oxide and correlation with lymph node metastasis and poor prognosis |
| Q93591876 | Cytosol and nuclear estrogen receptors (occupied and unoccupied sites) and progesterone receptors in human breast cancer |
| Q36619337 | Cytotoxic drugs efficacy correlates with adipose tissue docosahexaenoic acid level in locally advanced breast carcinoma. |
| Q37157593 | DBCG trial 89B comparing adjuvant CMF and ovarian ablation: similar outcome for eligible but non-enrolled and randomized breast cancer patients |
| Q73847779 | DNA copy number changes detected by comparative genomic hybridization and their association with clinicopathologic parameters in breast tumors |
| Q35838435 | DNA flow cytometric analysis and prognosis of axillary lymph node-negative breast carcinoma |
| Q73665779 | DNA hypomethylation in breast cancer: an independent parameter of tumor progression? |
| Q43538885 | DNA ploidy and other results of DNA flow cytometry as prognostic factors in operable breast cancer: 10 year results of a randomised study |
| Q51024315 | DNA ploidy and p53 expression correlate with survival and cell proliferative activity in male breast carcinoma. |
| Q67912285 | DNA ploidy and the expression of tissue-carcinoembryonic antigen in grade III carcinoma of the breast |
| Q34732984 | Decreased HCRP1 expression is associated with poor prognosis in breast cancer patients |
| Q91692822 | Deep Learning for Semantic Segmentation vs. Classification in Computational Pathology: Application to Mitosis Analysis in Breast Cancer Grading |
| Q35989958 | Defining the role of PET-CT in staging early breast cancer |
| Q33848003 | Demonstration of carcinoembryonic antigen in human breast carcinomas by the immunoperoxidase technique |
| Q41668126 | Description of a new human breast cancer cell line, IIB-BR-G, established from a primary undifferentiated tumor |
| Q39009511 | Descriptive analysis of molecular subtypes in Tunisian breast cancer |
| Q73119176 | Detection and quantitation by fluorescence in situ hybridization (FISH) and image analysis of HER-2/neu gene amplification in breast cancer fine-needle samples |
| Q35994299 | Detection by a human monoclonal antibody of a glycoprotein associated with malignant proliferation of mammary epithelial cells |
| Q44211837 | Detection of estrogen receptor proteins in breast tumors using an improved APAAP immunohistochemical technique |
| Q72380733 | Detection of intraoperative tumor cell dissemination in patients with breast cancer by use of reverse transcription and polymerase chain reaction |
| Q35158293 | Determination of estrogen receptors in paraffin-embedded tissue. Techniques and the value in breast cancer treatment |
| Q42153486 | Determination of placental ferritin (PLF)-positive lymphocytes in women in early stages of breast cancer |
| Q45237144 | Determination of threshold values for determining the size of the fraction of steroid hormone receptor-positive tumor cells in paraffin-embedded breast carcinomas |
| Q78733610 | Deterministic models for breast cancer progression: application to the association between mammographic parenchymal pattern and histologic grade of breast cancers |
| Q40260082 | Development and validation of an app-based cell counter for use in the clinical laboratory setting |
| Q37211298 | Diagnostic distance of high grade prostatic intraepithelial neoplasia from normal prostate and adenocarcinoma |
| Q71989514 | Difference in thymidylate synthetase activity in involved nodes compared with primary tumor in breast cancer patients |
| Q48696094 | Differences in Multi-Modal Ultrasound Imaging between Triple Negative and Non-Triple Negative Breast Cancer |
| Q73420853 | Differences in genetic alterations between primary lobular and ductal breast cancers detected by comparative genomic hybridization |
| Q87834246 | Differences in subtype distribution between screen-detected and symptomatic invasive breast cancer and their impact on survival |
| Q68248752 | Differences in tetranectin immunoreactivity between benign and malignant breast tissue |
| Q46827610 | Different clinical impact of estradiol receptor determination according to the analytical method: A study on 1940 breast cancer patients over a period of 16 consecutive years. |
| Q67671920 | Different lectin-binding patterns in primary breast cancers and their metastases |
| Q40195184 | Different methods of pretreatment Ki-67 labeling index evaluation in core biopsies of breast cancer patients treated with neoadjuvant chemotherapy and their relation to response to therapy |
| Q35976553 | Differential biological significance of tissue-type and urokinase-type plasminogen activator in human breast cancer |
| Q73062164 | Differential expression of Bax and Bcl-2 in the assessment of cellular dynamics in fine-needle samples of primary breast carcinomas |
| Q34147751 | Differential gene expression in primary breast tumors associated with lymph node metastasis |
| Q35833680 | Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas |
| Q57337284 | Differentiation antigens expressed by epithelial cells in the lactating breast are also detectable in breast cancers |
| Q53570090 | Differentiation of human breast carcinomas: an immunohistological study of appropriate and inappropriate protein production. |
| Q41503576 | Differentiation state and invasiveness of human breast cancer cell lines |
| Q38104997 | Diffusion-weighted MRI in pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer |
| Q35982849 | Discordant results between radioligand and immunohistochemical assays for steroid receptors in breast carcinoma |
| Q79334587 | Disease-specific and event-free survival in breast cancer patients: a hospital-based study between 1990 and 2001 |
| Q33897072 | Dissecting the Biological Heterogeneity within Hormone Receptor Positive HER2 Negative Breast Cancer by Gene Expression Markers Identifies Indolent Tumors within Late Stage Disease |
| Q33624965 | Distinguishing between benign and malignant melanocytic nevi by in vivo multiphoton microscopy |
| Q36614283 | Distinguishing blood and lymph vessel invasion in breast cancer: a prospective immunohistochemical study |
| Q36327177 | Distribution of Ki-67 values within HER2 & ER/PgR expression variants of ductal breast cancers as a potential link between IHC features and breast cancer biology |
| Q72239442 | Distribution of Tn antigen recognized by an anti-Tn monoclonal antibody (MLS128) in normal and malignant tissues of the digestive tract |
| Q77306156 | Does breast cancer grade worsen with time? Evidence from breast screening |
| Q68747786 | Does delay in diagnosis of breast cancer affect survival? |
| Q39647551 | Does delay in fixation affect the number of mitotic figures in processed tissue? |
| Q33196163 | Does the correlation between EBNA-1 and p63 expression in breast carcinomas provide a clue to tumorigenesis in Epstein-Barr virus-related breast malignancies? |
| Q45250061 | Does the degree of cell lesion in breast cancer after inductive chemotherapy have any prognostic value? |
| Q43664385 | Down regulation of the tumor suppressor gene maspin in breast carcinoma is associated with a higher risk of distant metastasis |
| Q47249948 | Downregulation of Muc1 in MMTV-c-Neu tumors |
| Q21195153 | Downregulation of the anaphase-promoting complex (APC)7 in invasive ductal carcinomas of the breast and its clinicopathologic relationships |
| Q39699307 | Dual-frequency ultrasound activation of nanomicellar doxorubicin in targeted tumor chemotherapy |
| Q66987397 | Duct Elastosis in Infiltrating Carcinoma of the Breast |
| Q81484622 | Ductal breast carcinoma develops through different patterns of chromosomal evolution |
| Q40852260 | Ductal carcinoma in situ (intraductal carcinoma) of the breast treated with breast-conserving surgery and definitive irradiation. Correlation of pathologic parameters with outcome of treatment |
| Q52884542 | Ductal carcinoma in situ of the breast. Heterogeneity of individual lesions. |
| Q43999564 | Dynamic MRI enhanced with albumin-(Gd-DTPA)30 or ultrasmall superparamagnetic iron oxide particles (NC100150 injection) for the measurement of microvessel permeability in experimental breast tumors. |
| Q51872094 | Dynamic infrared imaging in identification of breast cancer tissue with combined image processing and frequency analysis. |
| Q48500517 | E-cadherin quantitative immunocytochemical assays in breast carcinomas |
| Q36623198 | EBAG9/RCAS1 in human breast carcinoma: a possible factor in endocrine-immune interactions |
| Q52426461 | EGF binding is quantitatively related to growth in node-positive breast cancer. |
| Q39116530 | EGFR overexpression relates to triple negative profile and poor prognosis in breast cancer patients in Tunisia |
| Q77495138 | ERBB2 oncogene in human breast cancer and its clinical significance |
| Q36648472 | Early changes in apoptosis and proliferation following primary chemotherapy for breast cancer |
| Q43557996 | Early distant relapse in "node-negative" breast cancer patients is not predicted by occult axillary lymph node metastases, but by the features of the primary tumour |
| Q42510894 | Effect of ASCO/CAP guidelines for determining ER status on molecular subtype. |
| Q45806561 | Effect of drying and storage at 25 degrees C on immunological reactivity of hepatitis A virus antigen in stool specimens |
| Q36009189 | Effect of obesity on molecular characteristics of invasive breast tumors: gene expression analysis in a large cohort of female patients |
| Q40159535 | Effect of serum on cells cultured from human mammary tumors |
| Q37341753 | Effects of the expression of leptin and leptin receptor (OBR) on the prognosis of early-stage breast cancers |
| Q36458775 | Efficacy of adjuvant chemotherapy according to hormone receptor status in young patients with breast cancer: a pooled analysis |
| Q74699910 | Eight-year results of a prospective non-randomised study on therapy of small breast cancer. The German Breast Cancer Study Group (GBSG) |
| Q40125955 | Elevated BUBR1 expression is associated with poor survival in early breast cancer patients: 15-year follow-up analysis |
| Q33994291 | Elevated expression of myosin X in tumours contributes to breast cancer aggressiveness and metastasis |
| Q34263132 | Elevated insulin receptor content in human breast cancer |
| Q53977874 | Endoscopic exploration and lymph node sampling of the axilla. Preliminary findings of a randomized pilot study comparing clinical and anatomo-pathologic results of endoscopic axillary lymph node sampling with traditional surgical treatment. |
| Q34253125 | Enzyme pathology and the histologic categorization of human lung tumors: The continuum of quantitative biochemical indices of neoplasticity |
| Q39838001 | Enzyme studies in human breast tumours |
| Q44556147 | Enzyme-linked immunosorbent assay of pS2 in breast cancers, benign tumors, and normal breast tissues. Correlation with prognosis and adjuvant hormone therapy |
| Q30251732 | Epidemiologic evidence of slow growing, nonprogressive or regressive breast cancer: A systematic review |
| Q67902986 | Epidermal growth factor receptor expression as a prognostic indicator in breast cancer |
| Q43695203 | Epidermal growth factor receptor expression in 780 breast cancer patients: a reappraisal of the prognostic value based on an eight-year median follow-up |
| Q68463883 | Epidermal growth factor receptor in human breast cancers: Correlation with estrogen and progesterone receptors |
| Q36466662 | Epidermal growth factor receptor status of histological sub-types of breast cancer |
| Q70296813 | Epidermal growth factor receptors and prognosis in primary breast cancer |
| Q68132983 | Epidermal growth factor receptors in human breast cancer: a plea for standardisation of assay methodology |
| Q69900051 | Epidermal-growth-factor receptor status as predictor of early recurrence of and death from breast cancer |
| Q48212974 | Epigenetic silencing of the candidate tumor suppressor gene PROX1 in sporadic breast cancer |
| Q34543775 | Epstein-Barr virus as a marker of biological aggressiveness in breast cancer |
| Q71989529 | ErbB-2 oncoprotein overexpression in breast carcinoma: Inverse correlation with biochemically- and immunohistochemically-determined hormone receptors |
| Q43782367 | Estimating the benefits of adjuvant systemic therapy for women with early breast cancer. |
| Q68302591 | Estrogen and Progesterone Receptors as Prognostic Factors in Breast Cancer |
| Q39639564 | Estrogen and progesterone receptor determinations in breast cancer. Technology, biology and clinical significance |
| Q36647054 | Estrogen and progesterone receptors in breast cancer in Black Americans: Correlation of receptor data with tumor differentiation |
| Q39503412 | Estrogen and progesterone receptors in human breast cancer. Correlation with histologic subtype and degree of differentiation |
| Q41054233 | Estrogen and progestogen cytosol receptors in human breast carcinoma (author's transl) |
| Q79452035 | Estrogen receptor alpha-negative and progesterone receptor-positive breast cancer: lab error or real entity? |
| Q35793341 | Estrogen receptor beta is coexpressed with ERalpha and PR and associated with nodal status, grade, and proliferation rate in breast cancer |
| Q40119900 | Estrogen receptor concentrations in 269 cases of histologically classified human breast cancer |
| Q52234534 | Estrogen receptor negative and progesterone receptor positive primary breast cancer: pathological characteristics and clinical outcome. Institut Curie Breast Cancer Study Group. |
| Q40296429 | Estrogen receptor status and response to polychemotherapy in advanced breast cancer |
| Q51293206 | Evaluation of BRCA1 mutations in an unselected patient population with triple-negative breast cancer. |
| Q36029095 | Evaluation of immunoreactivity with monoclonal antibody NCRC 11 in breast carcinoma |
| Q52641638 | Evaluation of shape descriptors for the morphometric analysis of cell nuclei. |
| Q58603302 | Evaluation of the Predictive and Prognostic Values of Stromal Tumor-Infiltrating Lymphocytes in HER2-Positive Breast Cancers treated with neoadjuvant chemotherapy |
| Q55024796 | Evaluation of the interobserver agreement in the number of mitotic figures of breast carcinoma as simulation of quality monitoring in the Japan National Surgical Adjuvant Study of Breast Cancer (NSAS-BC) protocol. |
| Q63977941 | Evaluation of the pathologic and prognostic correlates of estrogen receptors in primary breast cancer |
| Q46813500 | Evaluation of the prognostic and predictive value of HER-1/EGFR in breast cancer patients participating in a randomized study with dose-dense sequential adjuvant chemotherapy. |
| Q46991232 | Evaluation of the prognostic value of HER-2 and VEGF in breast cancer patients participating in a randomized study with dose-dense sequential adjuvant chemotherapy |
| Q43508556 | Evidence against association between wet cerumen and breast cancer |
| Q36618879 | Exclusion of a major role for the PTEN tumour-suppressor gene in breast carcinomas |
| Q79768629 | Expression and clinical signification of cytosolic hyaluronan levels in invasive breast cancer |
| Q35833394 | Expression and prognostic significance of apolipoprotein D in breast cancer. |
| Q24800181 | Expression and prognostic significance of lysozyme in male breast cancer |
| Q44048215 | Expression of ALDH1 in axillary lymph node metastases is a prognostic factor of poor clinical outcome in breast cancer patients with 1-3 lymph node metastases |
| Q40148388 | Expression of B7-H1 in breast cancer patients is strongly associated with high proliferative Ki-67-expressing tumor cells. |
| Q34538321 | Expression of B7-H3, a potential factor of tumor immune evasion in combination with the number of regulatory T cells, affects against recurrence-free survival in breast cancer patients |
| Q33772874 | Expression of BMI-1 and Mel-18 in breast tissue--a diagnostic marker in patients with breast cancer |
| Q73707441 | Expression of Bcl-2 protein in human primary breast carcinomas and its correlation with multifocality, histopathological types and prognosis |
| Q36332426 | Expression of CPEB4 in invasive ductal breast carcinoma and its prognostic significance |
| Q90911150 | Expression of FGD3 gene as prognostic factor in young breast cancer patients |
| Q42768744 | Expression of HLA-A, -B, -C, -DR, -DP, -DQ, and of HLA-D-associated invariant chain (Ii) in non-neoplastic mammary epithelium, fibroadenoma, adenoma, and carcinoma of the breast. |
| Q90093804 | Expression of Histo-blood Group Antigens in Tumor and Adjacent Normal Breast Tissues as Prognostic Markers of Breast Carcinoma |
| Q70716819 | Expression of beta 1 integrins in non-neoplastic mammary epithelium, fibroadenoma and carcinoma of the breast |
| Q36115645 | Expression of c-erbB3 protein in primary breast carcinomas |
| Q57937526 | Expression of c-myc, erbB-2, p53 and nm23-H1 gene product in benign and malignant breast lesions: coexpression and correlation with clinicopathologic parameters |
| Q42510313 | Expression of calretinin in high-grade hormone receptor-negative invasive breast carcinomas: correlation with histological and molecular subtypes. |
| Q35984695 | Expression of cytochrome P450IA in breast cancer |
| Q35982533 | Expression of ecto-5'-nucleotidase (CD73) in normal mammary gland and in breast carcinoma |
| Q71539219 | Expression of endothelin-1 immunoreactivity in breast cancer |
| Q69053521 | Expression of epidermal growth factor receptor in benign and malignant primary tumours of the breast |
| Q73207824 | Expression of inducible nitric oxide synthase in human breast cancer depends on tumor grade |
| Q35588605 | Expression of insulin receptor substrate 1 in primary breast cancer and lymph node metastases. |
| Q71784070 | Expression of insulin-like growth factor I (IGF-I) in female breast cancer as related to established prognostic factors and long-term prognosis |
| Q54054136 | Expression of mediated P-glycoprotein multidrug resistance related to Tc-99m MIBI scintimammography results. |
| Q71569343 | Expression of p53 and bcl-2 in correlation to clinicopathological parameters, hormone receptor status and DNA ploidy in breast cancers |
| Q41585662 | Expression of pS2 protein in breast cancer |
| Q35976626 | Expression of pepsinogen C in human breast tumours and correlation with clinicopathologic parameters |
| Q72317046 | Expression of sialosyl-Tn antigen (monoclonal antibody MLS102 reactive) in normal tissues and malignant tumors of the digestive tract |
| Q73412818 | Expression of sialyl-Tn in breast cancer. Correlation with prognostic parameters |
| Q41851439 | Expression of sialyl-Tn predicts the effect of adjuvant chemotherapy in node-positive breast cancer |
| Q36138965 | Expression of the androgen receptor and an androgen-responsive protein, apolipoprotein D, in human breast cancer |
| Q54220490 | Expression of the multidrug-resistance gene product in untreated human breast cancer and its relationship to prognostic markers. |
| Q35981528 | Expression of the oestrogen regulated pNR-2 mRNA in human breast cancer: relation to oestrogen receptor mRNA levels and response to tamoxifen therapy |
| Q35773929 | Expression of topoisomerase IIalpha is associated with rapid cell proliferation, aneuploidy, and c-erbB2 overexpression in breast cancer |
| Q35978421 | Expression of transforming growth factor alpha, amphiregulin and cripto-1 in human breast carcinomas. |
| Q56777939 | Extended radical mastectomy versus simple mastectomy followed by radiotherapy in primary breast cancer. A fifty-year follow-up to the Copenhagen Breast Cancer randomised study |
| Q61970397 | Extensive and predominant in situ component in breast carcinoma: their influence on treatment results after breast-conserving therapy |
| Q41871478 | Factors Associated with (18)F-Fluorodeoxyglucose Uptake in T1 and T2 Invasive Ductal Carcinoma of the Breast. |
| Q68856475 | Factors influencing survival and prognosis in early breast carcinoma (T1N0M0-T1N1M0). Assessment of 644 patients with median follow-up of 18 years |
| Q34025189 | Factors influencing the incidence and prognosis of canine mammary tumours. |
| Q34072703 | Fascin is a key regulator of breast cancer invasion that acts via the modification of metastasis-associated molecules |
| Q34684585 | Feasibility of MR metabolomics for immediate analysis of resection margins during breast cancer surgery |
| Q36040773 | Fibrosis as in indication of time in infiltrating breast cancer and its importance in prognosis |
| Q77425692 | Fibrotic focus in infiltrating ductal carcinoma of the breast: a significant histopathological prognostic parameter for predicting the long-term survival of the patients |
| Q54950458 | Fibrotic focus in invasive ductal carcinoma of the breast: a histopathological prognostic parameter for tumor recurrence and tumor death within three years after the initial operation. |
| Q55397736 | Fibrotic focus in invasive ductal carcinoma: an indicator of high tumor aggressiveness. |
| Q50630417 | First-Line Palliative HER2-Targeted Therapy in HER2-Positive Metastatic Breast Cancer Is Less Effective After Previous Adjuvant Trastuzumab-Based Therapy. |
| Q40881376 | Flow cytometric (DNA content and S-phase fraction) analysis of breast cancer |
| Q35983140 | Flow cytometric analysis of cell surface carbohydrates in metastatic human breast cancer |
| Q35982247 | Flow cytometric analysis of tumour infiltrating lymphocytes in breast cancer |
| Q38490325 | Flow cytometric and histological analysis of ductal carcinoma in situ of the breast |
| Q44958488 | Flow cytometric detection of multifocal DNA aneuploid cell populations in mastectomy specimens containing a primary breast carcinoma |
| Q34052360 | Flow cytometry in primary breast carcinomas. Prognostic impact of proliferative activity |
| Q73887315 | Flow cytometry in primary breast carcinomas: prognostic impact of multiploidy and hypoploidy |
| Q73665791 | Fluorescence in situ hybridization assessment of chromosome 8 copy number in stage I and stage II infiltrating ductal carcinoma of the breast |
| Q38428225 | Frequency of the basal-like phenotype in African breast cancer |
| Q34094254 | Frequent loss of WWOX expression in breast cancer: correlation with estrogen receptor status |
| Q45269391 | Frozen section- frozen attitudes |
| Q41120962 | Future directions for the American Joint Committee on Cancer |
| Q24657350 | GATA-3 links tumor differentiation and dissemination in a luminal breast cancer model |
| Q42501865 | GSTP1 expression predicts poor pathological complete response to neoadjuvant chemotherapy in ER-negative breast cancer |
| Q35527125 | GSTPi-positive tumour microenvironment-associated fibroblasts are significantly associated with GSTPi-negative cancer cells in paired cases of primary invasive breast cancer and axillary lymph node metastases |
| Q72494899 | Gastric cancer and cimetidine: does delay in diagnosis matter? |
| Q37496869 | Gene and chromosomal alterations in sporadic breast cancer: correlation with histopathological features and implications for genesis and progression |
| Q41252109 | Gene expression profiling of human lymph node metastases and matched primary breast carcinomas: clinical implications |
| Q34698991 | Gene-expression signatures can distinguish gastric cancer grades and stages |
| Q38770897 | General principles of grading lesions in diagnostic histopathology |
| Q40989573 | Genetic evolution of breast cancers. III: Age-dependent variations in the correlations between biological indicators of prognosis |
| Q83387766 | Genetic variations in transcription factor 7-like 2 (TCF7L2) gene: association of TCF7L2 rs12255372(G/T) or rs7903146(C/T) with breast cancer risk and clinico-pathological parameters |
| Q69377616 | Genomic DNA analysis of the estrogen receptor gene in breast cancer |
| Q33860280 | Genomic Heterogeneity of Breast Tumor Pathogenesis |
| Q41157174 | Glutathione localisation in benign and malignant human breast lesions |
| Q42936428 | Glyoxalase I Ala111Glu gene polymorphism: No association with breast cancer risk but correlated with absence of progesterone receptor |
| Q50940454 | Grading breast cancer on microarray samples: comparison with Nottingham grade, and use of boosting classification. |
| Q80215596 | Grading invasive ductal carcinoma of the breast: advantages of using automated proliferation index instead of mitotic count |
| Q53344993 | Grading system for lymph vessel tumor emboli: significant outcome predictor for patients with invasive ductal carcinoma of the breast who received neoadjuvant therapy. |
| Q35856539 | Growth fractions and estrogen receptors in human breast cancers as determined in situ with monoclonal antibodies. |
| Q37211625 | Growth fractions in breast cancers determined in situ with monoclonal antibody Ki-67. |
| Q35066948 | Guideline conformity treatment in young women with early-onset breast cancer in Germany |
| Q24682023 | H19 overexpression in breast adenocarcinoma stromal cells is associated with tumor values and steroid receptor status but independent of p53 and Ki-67 expression |
| Q36446996 | Helix pomatia and Ulex europeus lectin binding in human breast carcinoma. |
| Q64944748 | Helping Patients Make Informed Choices: A Randomized Trial of a Decision Aid for Adjuvant Chemotherapy in Lymph Node-Negative Breast Cancer |
| Q91918656 | High GD2 expression defines breast cancer cells with enhanced invasiveness |
| Q33747365 | High expression of gabarapl1 is associated with a better outcome for patients with lymph node-positive breast cancer |
| Q46788885 | High prognostic significance of residual disease after neoadjuvant chemotherapy: a retrospective study in 710 patients with operable breast cancer. |
| Q36484592 | High rates of breast conservation for large ductal and lobular invasive carcinomas combining multimodality strategies |
| Q43167734 | High-grade breast cancers include both highly sensitive and highly resistant subsets to cytotoxic chemotherapy |
| Q90725488 | Higher Tumor Cellularity in Resected Pancreatic Ductal Adenocarcinoma Is a Negative Prognostic Indicator |
| Q47698092 | Histiocytoid breast carcinoma: histological, immunohistochemical, ultrastructural, cytological and clinicopathological studies |
| Q70147967 | Histologic features associated with long-term survival in breast cancer |
| Q73867829 | Histologic grade, stage, and survival in breast carcinoma: comparison of African American and Caucasian women |
| Q52920767 | Histologic grading in breast cancer--reproducibility between seven pathologic departments. South Sweden Breast Cancer Group. |
| Q50661847 | Histologic grading is an independent prognostic factor in invasive lobular carcinoma of the breast. |
| Q52883876 | Histologic grading of breast carcinoma. A reproducibility study. |
| Q100737236 | Histologic grading of breast carcinoma: a multi-institution study of interobserver variation using virtual microscopy |
| Q41313021 | Histologic malignancy grading of invasive ductal breast carcinoma. A regression analysis of prognostic factors in low-risk carcinomas from a multicenter trial |
| Q40853372 | Histologic types and hormone receptors in breast cancer in men: a population-based study in 282 United States men. |
| Q53408408 | Histologic types of breast carcinoma in relation to international variation and breast cancer risk factors. WHO Collaborative Study of Neoplasia and Steroid Contraceptives. |
| Q38757433 | Histological Grade and Immunohistochemical Biomarkers of Breast Cancer: Correlation to Ultrasound Features |
| Q43596229 | Histological Grading of Breast Carcinoma |
| Q44115152 | Histological and immunohistochemical analysis of apocrine breast carcinoma |
| Q55259141 | Histological factors associated with initial bone metastasis of invasive ductal carcinoma of the breast. |
| Q36043167 | Histological grade and other prognostic factors in relation to survival of patients with breast cancer |
| Q72477323 | Histological grade and response to endocrine therapy in breast cancer |
| Q36466679 | Histological grade and steroid receptor content of primary breast cancer--impact on prognosis and possible modes of action |
| Q53220568 | Histological grade of invasive carcinoma of the breast assessed on needle core biopsy - modifications to mitotic count assessment to improve agreement with surgical specimens. |
| Q36027935 | Histological grade, elastosis, DNA ploidy and the response to chemotherapy of breast cancer |
| Q43997335 | Histological grade, p53, HER2 and hormone receptor status of synchronous bilateral breast carcinoma |
| Q36047044 | Histological grading and clinical stage at presentation in breast carcinoma |
| Q36038027 | Histological grading in breast cancer |
| Q36037032 | Histological grading in carcinoma of the breast |
| Q68078160 | Histological grading of breast cancer. Interobserver, reproducibility and prognostic significance |
| Q57297578 | Histological grading of breast cancer: a study of reproducibility of consensus grading |
| Q53364525 | Histological grading of invasive breast carcinoma--a simplification of existing methods in a large conservation series with long-term follow-up. |
| Q34205291 | Histology image analysis for carcinoma detection and grading |
| Q36038682 | Histology in breast cancer prognosis |
| Q52745197 | Histopathological characteristics and oestrogen receptor content in primary breast carcinoma |
| Q38417070 | Histopathological prognostic factors in early breast carcinoma: an evaluation of cell proliferation in carcinoma cells |
| Q37170184 | Histopathological systems of breast cancer classification: reproducibility and clinical significance |
| Q73369582 | Histopathology grading in small breast cancers < or = 10 mm--results from an area with mammography screening |
| Q36116041 | Histopathology of breast cancer in relation to age. |
| Q33839987 | Histopathology of breast cancer in young women in relation to use of oral contraceptives |
| Q35623048 | Hormone Receptor Expression in Male Breast Cancers |
| Q58244337 | Hormone Receptors as Prognostic Factors in Female: Breast Cancer |
| Q40877143 | Hormone therapy following breast and uterine cancer |
| Q53724767 | Host resistance and survival in carcinoma of breast: a study of 104 cases of medullary carcinoma in a series of 1,411 cases of breast cancer followed for 20 years. |
| Q37215183 | How to develop and use a Bayesian Belief Network |
| Q35981979 | Human breast cancer: identification of populations with a high risk of early relapse in relation to both oestrogen receptor status and c-erbB-2 overexpression |
| Q44942306 | Human breast tumors: a comparison between the biochemical method of measuring estrogen and progesterone receptors and that of an immunohistochemical method |
| Q24642830 | Human kallikrein gene 13 (KLK13) expression by quantitative RT-PCR: an independent indicator of favourable prognosis in breast cancer |
| Q39497933 | Human mucinous breast carcinomas and their lymph node metastases. A histological review of 247 cases |
| Q44798703 | Hyaluronan (hyaluronic acid) and hyaluronectin in the extracellular matrix of human breast carcinomas: comparison between invasive and non-invasive areas |
| Q33630831 | Hypoxia inducible factor 1alpha gene (HIF-1alpha) splice variants: potential prognostic biomarkers in breast cancer. |
| Q36342924 | Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells |
| Q35777081 | Identification of Gene-Expression Signatures and Protein Markers for Breast Cancer Grading and Staging |
| Q70970943 | Identification of amplified DNA sequences in breast cancer and their organization within homogeneously staining regions |
| Q33975072 | Identification of differentially expressed genes in breast tumors from African American compared with Caucasian women |
| Q72556503 | Identification of immunoreactive tissue kallikrein in human ductal breast carcinomas |
| Q47420879 | Identification of key gene modules and pathways of human breast cancer by co-expression analysis |
| Q36617734 | Identification of women with early breast cancer by analysis of p43-positive lymphocytes |
| Q38241276 | Illuminating breast cancer invasion: diverse roles for cell-cell interactions |
| Q52465302 | Image Analysis Cytology for DNA Determination in Breast and Prostate Cancer |
| Q74720116 | Image cytometric bcl-2:bax and bcl-2:bcl-x ratios in invasive breast carcinoma: correlation with prognosis |
| Q40682459 | Image cytometry: current applications and future trends |
| Q43202265 | Immunocytochemical assessment of sigma-1 receptor and human sterol isomerase in breast cancer and their relationship with a series of prognostic factors |
| Q72538851 | Immunocytochemical detection of DNA topoisomerase type II in primary breast carcinomas: correlation with clinico-pathological features |
| Q69106828 | Immunocytochemical reactivity of breast cancer tissue with antibodies to neuron-specific enolase and an adenocarcinoma-associated glycolipid antigen |
| Q34489356 | Immunocytochemical staining of breast carcinoma with the monoclonal antibody NCRC 11: a new prognostic indicator |
| Q35816773 | Immunocytochemical staining of progesterone receptor in paraffin sections of human breast cancers |
| Q36465780 | Immunocytochemical staining of proliferating cells in fine needle aspiration smears of primary and metastatic breast tumours |
| Q67491834 | Immunocytochemistry and in situ hybridisation of epidermal growth factor receptor and relation to prognostic factors in breast cancer |
| Q41585896 | Immunocytochemistry in the assessment of pS2 protein expression in fine needle aspiration cytology from breast carcinoma |
| Q43828311 | Immunodetection in fine-needle aspirates and multiparametric (SAMBA) image analysis. Receptors (monoclonal antiestrogen and antiprogesterone) and growth fraction (monoclonal Ki67) evaluation in breast carcinomas |
| Q59647394 | Immunohistochemical Characteristics of Human Milk-fat Globule Antibodies in Predicting Chest Wall and Distant Metastasis After Mastectomy for Localized Cancer of the Breast |
| Q37425194 | Immunohistochemical Subtypes of Breast Cancer: Correlation with Clinicopathological and Radiological Factors. |
| Q35773959 | Immunohistochemical analysis of retinoic acid receptor-alpha in human breast tumors: retinoic acid receptor-alpha expression correlates with proliferative activity |
| Q72825296 | Immunohistochemical and biochemical measurement of estrogen and progesterone receptors in primary breast cancer. Correlation of histopathology and prognostic factors |
| Q38485846 | Immunohistochemical demonstration of androgen receptor in breast cancer and its relationship to other prognostic factors |
| Q46208281 | Immunohistochemical demonstration of carcinoembryonic antigen (CEA) in 120 mammary carcinomas and its correlation with tumor type, grading, staging plasma-CEA, and biochemical receptor status |
| Q47771117 | Immunohistochemical detection of Ki-67 and PCNA in canine mammary tumors: relationship to clinical and pathologic variables. |
| Q68865453 | Immunohistochemical detection of laminin in 98 human breast carcinomas: a light and electron microscopic study |
| Q72378682 | Immunohistochemical detection of metallothionein in primary breast carcinomas and their axillary lymph node metastases |
| Q72080084 | Immunohistochemical detection of p53 protein in mammary carcinoma: An important new independent indicator of prognosis? |
| Q68808355 | Immunohistochemical detection of progesterone receptor in formalin-fixed and paraffin-embedded breast cancer tissue using a monoclonal antibody |
| Q43651286 | Immunohistochemical expression of gonadotropin releasing hormone receptor in human breast carcinoma |
| Q44077534 | Immunohistochemical expression of oncological proliferation markers in the hearts of rats during normal pregnancy |
| Q59647395 | Immunohistochemical reaction to human milk fat globule antibodies and breast cancer differentiation |
| Q42459789 | Immunohistochemical studies on expression of human vascular smooth muscle myosin heavy chain isoforms in normal mammary glands, benign mammary disorders and mammary carcinomas |
| Q73224117 | Immunohistochemical study of Cell Cycle Modulators in G(1)-S Transition in Clinical Breast Cancer Tissue |
| Q37256902 | Immunohistochemical study of topoisomerase II-alpha expression in primary ductal carcinoma of the breast |
| Q69679876 | Immunohistochemical versus biochemical estrogen-receptor and progesterone-receptor analysis: correlation with histological parameters |
| Q44394208 | Immunohistological detection of tissue factor in normal and abnormal human mammary glands using monoclonal antibodies |
| Q40943415 | Immunolocalization of the fodrin, E-cadherin, and beta-catenin adhesion complex in infiltrating ductal carcinoma of the breast-comparison with an in vitro model |
| Q66961695 | Immunological characterization of mononuclear cells and morphological findings in patients with mammary carcinoma |
| Q36040472 | Immunological significance of the morphological changes in lymph nodes draining breast cancer |
| Q71835785 | Immunosuppression by breast cancer associated p43-effect of immunomodulators |
| Q99551766 | Immunotyping of tumor-infiltrating lymphocytes in triple-negative breast cancer and genetic characterization |
| Q38334586 | Impact of DNA repair genes polymorphism (XPD and XRCC1) on the risk of breast cancer in Egyptian female patients. |
| Q54242111 | Impact of SOX18 expression in cancer cells and vessels on the outcome of invasive ductal breast carcinoma. |
| Q50567683 | Impact of axillary dissection on staging and regional control in breast tumors < or = 10 mm--the DBCG experience. The Danish Breast Cancer Cooperative Group (DBCG), Rigshisoutalet, Copenhagen, Denmark. |
| Q53434834 | Impact of body mass index on clinical outcomes in triple-negative breast cancer. |
| Q53671085 | Impact of patient age on the outcome of primary breast carcinoma. |
| Q54664167 | Impact of tumor grade and host resistance on survival of women with breast cancer. |
| Q47786406 | Imprint cytology-based breast malignancy screening: an efficient nuclei segmentation technique |
| Q71789853 | Improved prognostication in small (pT1) breast cancers by image cytometry |
| Q50547512 | Improvement of prognosis in breast cancer in Denmark 1977-2006, based on the nationwide reporting to the DBCG Registry. |
| Q71835772 | Improvement of quality control for steroid receptor measurements: analysis of distributions in more than 40000 primary breast cancers. French Study Group on Tissue and Molecular Biopathology |
| Q36440712 | In situ hybridisation and S1 mapping show that the presence of infiltrating plasma cells is associated with poor prognosis in breast cancer |
| Q35856477 | In situ quantitation of inflammatory mononuclear cells in ductal infiltrating breast carcinoma. Relation to prognostic parameters |
| Q97544071 | Incidence and Predictors of Recurrence among Breast Cancer Patients in Black Lion Specialized Hospital Adult Oncology Unit, Addis Ababa, Ethiopia: Retrospective Follow-up Study with Survival Analysis |
| Q34404867 | Increased expression levels of WAVE3 are associated with the progression and metastasis of triple negative breast cancer |
| Q33700674 | Increasing late stage colorectal cancer and rectal cancer mortality demonstrates the need for screening: a population based study in Ireland, 1994-2010 |
| Q36647843 | Independent prognostic value of angiogenesis and the level of plasminogen activator inhibitor type 1 in breast cancer patients |
| Q51053686 | Independent prognostic value of screen detection in invasive breast cancer. |
| Q54457283 | Individual chemosensitivity of in vitro proliferating mammary and ovarian carcinoma cells in comparison to clinical results of chemotherapy. |
| Q43991238 | Inflammatory symptoms in breast cancer. Correlations with growth rate, clinicopathologic variables, and evolution |
| Q33911337 | Influence of Hormone Receptor Status on Spinal Metastatic Lesions in Patients with Breast Cancer |
| Q68533360 | Influence of smear preparation and fixatives on the DNA ploidy and the morphonuclear features of the MXT mammary tumor and normal tissues in the mouse |
| Q35370090 | Insight into the heterogeneity of breast cancer through next-generation sequencing |
| Q81261780 | Insulin-like growth factor-1 receptor (IGF-1R) expression does not predict for resistance to trastuzumab-based treatment in patients with Her-2/neu overexpressing metastatic breast cancer |
| Q74465252 | Integration of estrogen and progesterone receptors with pathological and molecular prognostic factors in breast cancer patients |
| Q59052690 | Intelligent CAD System for Automatic Detection of Mitotic Cells from Breast Cancer Histology Slide Images Based on Teaching-Learning-Based Optimization |
| Q92890756 | Intense basolateral membrane staining indicates HER2 positivity in invasive micropapillary breast carcinoma |
| Q46656752 | Intensified neoadjuvant chemotherapy in early-responding breast cancer: phase III randomized GeparTrio study |
| Q73976752 | Intercellular adhesion molecule expression in ductal carcinoma of the breast: correlation of immunohistochemical staining with cytologic smear pattern |
| Q52950362 | Intra-mammary tumor location does not influence prognosis but influences the prevalence of axillary lymph-node metastases. |
| Q39582187 | Intracellular filaments in human cancer cells: A histological study |
| Q33607816 | Intratumoral Morphological Heterogeneity of Breast Cancer As an Indicator of the Metastatic Potential and Tumor Chemosensitivity |
| Q38475017 | Intratumoral heterogeneity in primary breast carcinoma: study of concurrent parameters |
| Q64019057 | Intratumoural heterogeneity of proliferation in invasive breast carcinoma evaluated with MIBI antibody |
| Q52582782 | Introducing a novel highly prognostic grading scheme based on tumour budding and cell nest size for squamous cell carcinoma of the uterine cervix. |
| Q64115873 | Introduction to Digital Image Analysis in Whole-slide Imaging: A White Paper from the Digital Pathology Association |
| Q69844155 | Invasive apocrine carcinoma of the breast: a long term follow-up study of 34 cases |
| Q50473910 | Invasive breast carcinomas of no special type with osteoclast-like giant cells frequently have a luminal phenotype. |
| Q35086250 | Invasive lobular breast cancer: the prognostic impact of histopathological grade, E-cadherin and molecular subtypes |
| Q45191001 | Invasive lobular carcinoma: to grade or not to grade |
| Q38416143 | Is Pre-Operative Axillary Staging with Ultrasound and Ultrasound-Guided Fine-Needle Aspiration Reliable in Invasive Lobular Carcinoma of the Breast? |
| Q73308608 | Is invasive lobular carcinoma different from invasive ductal carcinoma? |
| Q74288176 | Is p53 a protein that predicts the response to chemotherapy in node negative breast cancer? |
| Q61758679 | Is the grading of breast carcinomas affected by a delay in fixation? |
| Q37116733 | Is the informational content of histopathological reports increasing? |
| Q41128582 | Is the thymidine labeling index a good prognostic marker in breast cancer? |
| Q70106818 | Kappa casein, lactalbumin and GCDFP 70 localization in human breast carcinomas: an immunohistochemical study using the avidin-biotin-peroxidase complex method |
| Q36136529 | Keratin 19 mRNA measurement to detect micrometastases in lymph nodes in breast cancer patients |
| Q36261767 | Ki-67 and caspase expression in breast carcinoma: does variance in locational sampling exist? |
| Q44323795 | Ki-67 expression in breast carcinoma: its association with grading systems, clinical parameters, and other prognostic factors--a surrogate marker? |
| Q40613614 | Ki-67 immunostaining activity is higher in positive axillary lymph nodes than in the primary breast tumor |
| Q67912089 | Ki-67 immunostaining in human breast tumors and its relationship to prognosis |
| Q35995507 | KiSS1/GPR54 and estrogen-related gene expression profiles in primary breast cancer |
| Q70755926 | Kinetic parameters and the course of the disease in breast cancer |
| Q41742563 | LEA.135 expression: an independent and favorable prognostic biomarker for patients with primary invasive breast cancer |
| Q36127428 | LEVELS OF PHOSPHOHEXOSE ISOMERASE IN CARCINOMATOUS BREAST TISSUE IN RELATION TO HISTOLOGICAL GRADING. |
| Q33683673 | Lack of prognostic significance of adiponectin immunohistochemical expression in patients with triple-negative breast cancer |
| Q71376691 | Lack of prognostic significance of the monoclonal antibody Ki-S1, a novel marker of proliferative activity, in node-negative breast carcinoma |
| Q35983100 | Lacking prognostic significance of beta 2-microglobulin, MHC class I and class II antigen expression in breast carcinomas |
| Q46383763 | Lactate and glycine-potential MR biomarkers of prognosis in estrogen receptor-positive breast cancers |
| Q44611664 | Limited Prognostic Value of c-erbB-2 Compared to uPA and PAI-1 in Primary Breast Carcinoma |
| Q53409654 | Lipid peroxidation, free radical production and antioxidant status in breast cancer. |
| Q92960226 | Lithocholic Acid, a Metabolite of the Microbiome, Increases Oxidative Stress in Breast Cancer |
| Q73764882 | Local and distant failures after limited surgery with positive margins and radiotherapy for node-negative breast cancer |
| Q45307585 | Local and distant recurrence after conservative management of "very low-risk" breast cancer are dependent events: a 10-year follow-up |
| Q44991383 | Local recurrences after conservative treatment of breast cancer: risk factors and influence on survival |
| Q44800541 | Localization of metallothionein in breast carcinomas. An immunohistochemical study |
| Q70022261 | Locoregional recurrences following radical external beam irradiation and interstitial implantation for operable breast cancer--a twenty three year experience |
| Q71376535 | Long term prognostic value of growth fraction determination by Ki-67 immunostaining in primary operable breast cancer |
| Q43621488 | Long-term prognosis of breast cancer patients with 10 or more positive lymph nodes treated with CMF. |
| Q61196265 | Long-term results (10 years) of intensive breast conserving therapy including a high-dose and large-volume interstitial brachytherapy boost (LDR/HDR) for T1/T2 breast cancer |
| Q64019007 | Loss of CD59 expression in breast tumours correlates with poor survival |
| Q55058076 | Loss of VLA-2 collagen receptor in breast carcinoma, facilitating invasion and metastasis. |
| Q57240039 | Loss of heterozygosity analysis at theBRCAloci in tumor samples from patients with familial breast cancer |
| Q44071038 | Loss of heterozygosity at pseudoautosomal regions in human breast cancer and association with negative hormonal phenotype |
| Q35830902 | Loss of heterozygosity on chromosome 17p13 in breast carcinomas identifies tumors with high proliferation index |
| Q36622439 | Lumpectomy with or without postoperative radiotherapy for breast cancer with favourable prognostic features: results of a randomized study |
| Q35157568 | Lymph node status as a guide to selection of available prognostic markers in breast cancer: the clinical practice of the future? |
| Q72494908 | Lymphatic and vascular channel involvement within infiltrative breast carcinomas as a guide to prognosis at the time of primary surgical treatment |
| Q36027061 | MDA-MB-231 breast cancer cells overexpressing single VEGF isoforms display distinct colonisation characteristics. |
| Q38983992 | MIB-1 index, S-phase fraction, mitotic figure count, and SBR histologic grading in invasive breast carcinoma: a comparative study |
| Q73551534 | MMP-2 positivity and age less than 40 years increases the risk for recurrence in premenopausal patients with node-positive breast carcinoma |
| Q40276305 | MR-determined metabolic phenotype of breast cancer in prediction of lymphatic spread, grade, and hormone status |
| Q46089577 | MRI assessment of microvascular characteristics in experimental breast tumors using a new blood pool contrast agent (MS-325) with correlations to histopathology. |
| Q31088675 | MRI tumor characterization using Gd-GlyMe-DOTA-perfluorooctyl-mannose-conjugate (Gadofluorine M), a protein-avid contrast agent |
| Q35746334 | MRP8/ABCC11 expression is regulated by dexamethasone in breast cancer cells and is associated to progesterone receptor status in breast tumors |
| Q36465864 | Macrophages in human breast disease: a quantitative immunohistochemical study |
| Q45936684 | Magnetic resonance characterization of tumor microvessels in experimental breast tumors using a slow clearance blood pool contrast agent (carboxymethyldextran-A2-Gd-DOTA) with histopathological correlation. |
| Q36041002 | Male breast cancer. 6. Factors influencing prognosis |
| Q50550918 | Male breast cancer.I. Histologic typing and grading of 187 Danish cases |
| Q71772058 | Male breast cancer: Austrian experience |
| Q89931288 | Male breast cancer: clinicopathological characterization of a National Danish cohort 1980-2009 |
| Q66894400 | Mammary cancers and pregnancy |
| Q38430374 | Mammographic and sonographic features of triple-negative invasive carcinoma of no special type |
| Q47109403 | Mammography and ultrasound effective features in differentiating basal-like and normal-like subtypes of triple negative breast cancer |
| Q36365514 | Mammography before post-operative radiotherapy in conservatively managed breast cancer patients: is it useful? |
| Q72919568 | Markers of prognosis in breast cancer--the relationship between binding of the lectin HPA and histological grade, SPF, and ploidy |
| Q36671053 | Matrix metalloproteinase-2 (MMP-2) is associated with survival in breast carcinoma |
| Q43540159 | Matrix metalloproteinase-2 (MMP-2) is associated with the risk for a relapse in postmenopausal patients with node-positive breast carcinoma treated with antiestrogen adjuvant therapy |
| Q68580158 | Measurement of DNA content and nuclear pleomorphism in metastatic variants of the B16 murine melanoma and hamster lymphoma and its liver metastasis using image analysis techniques |
| Q36466759 | Measurement of oestrogen receptor mRNA levels in human breast tumours |
| Q41342198 | Mechanism of action of adjuvant chemotherapy in early breast cancer |
| Q35984157 | Medullary carcinoma of the breast, proposal for a new simplified histopathological definition. Based on prognostic observations and observations on inter- and intraobserver variability of 11 histopathological characteristics in 131 breast carcinomas |
| Q83204469 | Meningeal carcinomatosis in breast cancer: prognostic factors and outcome |
| Q35962498 | Meta-analysis of the concordance of histological grade of breast cancer between core needle biopsy and surgical excision specimen |
| Q37232617 | Method for grading breast cancer |
| Q35986089 | Micro-anatomical quantitative optical imaging: toward automated assessment of breast tissues |
| Q55286259 | MicroRNA-17 and the prognosis of human carcinomas: a systematic review and meta-analysis. |
| Q33470698 | Microangiopathic haemolytic anaemia and mucin-forming adenocarcinoma |
| Q72403653 | Microcalcifications in breast carcinomas. A histological and histochemical study |
| Q33207940 | Microdissection and SAGE as a combined tool to reveal gene expression in ductal carcinoma in situ of the breast |
| Q58434089 | Microvessel density compared with the Chalkley count in a prognostic study of angiogenesis in breast cancer patients |
| Q36081001 | Microvessel quantitation in invasive breast cancer by staining for factor VIII-related antigen |
| Q35686841 | Mitosis detection in breast cancer pathology images by combining handcrafted and convolutional neural network features |
| Q36865613 | Mitosis in circulating tumor cells stratifies highly aggressive breast carcinomas |
| Q53141236 | Mitotic figure counts are significantly overestimated in resection specimens of invasive breast carcinomas. |
| Q41923291 | Mitotic indexes as prognostic predictors in female breast cancer |
| Q51964438 | Mixture model approach to tumor classification based on pharmacokinetic measures of tumor permeability. |
| Q52994246 | Modal Deoxyribonucleic Acid Value and Survival in Carcinoma of the Breast |
| Q38637968 | Modulation of SOX2 expression delineates an end-point for paclitaxel-effectiveness in breast cancer stem cells |
| Q34442167 | Molecular alterations associated with breast cancer mortality |
| Q39399933 | Molecular and clinicopathological markers of prognosis in breast cancer. |
| Q36744131 | Molecular and morphologic distinctions between infiltrating ductal and lobular carcinoma of the breast |
| Q53417262 | Molecular changes in primary breast tumors and the Nottingham Histologic Score. |
| Q38216166 | Molecular classification of breast cancer |
| Q39410000 | Molecular signatures in breast cancer. |
| Q37094017 | Molecular subtypes, histopathological grade and survival in a historic cohort of breast cancer patients |
| Q37195924 | Monitoring serum CEA in women with primary breast tumours positive for oestrogen receptor and with spread to lymph nodes |
| Q67893835 | Monoclonal 3c6f9 distribution in human breast carcinomas: image cytometry of immunocytochemical assays |
| Q72664158 | Monoclonal antibodies to the human mammary gland. II. Distribution of determinants in breast carcinomas |
| Q71355151 | Monoclonal antibodies to the human mammary gland: III. Monoclonal antibody LICR-LON-M18 identifies impaired expression and excess sialylation of the I(Ma) cell-surface antigen by primary breast carcinoma cells |
| Q72859993 | Monoclonal antibody BrE-3 participation in a multivariate prognostic model for infiltrating ductal carcinoma of the breast |
| Q38783398 | More than meets the eye: the changing face of histopathology |
| Q44387065 | Morphological predictors of survival in advanced gastric carcinoma univariate and multivariate analysis |
| Q44692374 | Morphological predictors of survival in colorectal carcinoma: univariate and multivariate analysis |
| Q53503859 | Morphology of male breast carcinoma in the evaluation of prognosis. |
| Q33838802 | Morphometric analysis of breast carcinoma: association with survival |
| Q43733900 | Morphometric grading in breast cancer: thresholds for mitotic counts. |
| Q36641732 | Morphometric grading of breast cancer: thresholds for tubular differentiation |
| Q36114892 | Morphometric grading of invasive ductal breast cancer. I. Thresholds for nuclear grade |
| Q93664031 | Morphometrical assessment of mean nuclear area in breast cancer in comparison with that of lymph node metastases |
| Q36692392 | Morphometrical malignancy grading is a valuable prognostic factor in invasive ductal breast cancer. |
| Q37208562 | Morphometry and breast cancer. II. Characterisation of breast cancer cells with high malignant potential in patients with spread to lymph nodes: preliminary results |
| Q72483601 | Morphometry for prognosis prediction in breast cancer |
| Q40550579 | Morphometry in histopathology |
| Q69578363 | Morphometry of breast cancer. I. Comparison of the primary tumours and the axillary lymph node metastases |
| Q34058091 | Most random gene expression signatures are significantly associated with breast cancer outcome |
| Q34289056 | Multi-field-of-view strategy for image-based outcome prediction of multi-parametric estrogen receptor-positive breast cancer histopathology: Comparison to Oncotype DX |
| Q41523907 | Multidrug resistance in breast cancer: a meta-analysis of MDR1/gp170 expression and its possible functional significance. |
| Q36663655 | Multiparameter DNA content analysis identifies distinct groups in primary breast cancer. |
| Q35586145 | Multiparameter flow cytometry as a tool for the detection of micrometastatic tumour cells in the sentinel lymph node procedure of patients with breast cancer |
| Q35818905 | Multiparametric analysis (SAMBA 200) of the progesterone receptor immunocytochemical assay in nonmalignant and malignant breast disorders |
| Q47698139 | Multiple developmental pathways of highly aggressive breast cancers disclosed by comparison of histological grades and c-erbB-2 expression patterns in both the non-invasive and invasive portions |
| Q36295007 | Multiple gene expression analysis reveals distinct differences between G2 and G3 stage breast cancers, and correlations of PKC eta with MDR1, MRP and LRP gene expression |
| Q66992140 | Multiple steroid receptors in human breast cancer. III. Relationships between steroid receptors and the state of differentiation and the activity of carcinomas throughout the pathologic features |
| Q43227553 | Multivariate modeling and prediction of breast cancer prognostic factors using MR metabolomics |
| Q34190980 | Mutation Analysis in the Coding Sequence of Thymidine Kinase 1 in Breast and Colorectal Cancer |
| Q73153665 | Mutational analysis of the NM23.H1 gene in human breast cancer |
| Q73114148 | Myoepithelial differentiation in high-grade invasive ductal carcinomas with large central acellular zones |
| Q35982467 | N-6 polyunsaturated fatty acids in human breast carcinoma phosphatidylethanolamine and early relapse |
| Q36263042 | NADH-Cytochrome b5 Reductase 3 Promotes Colonization and Metastasis Formation and Is a Prognostic Marker of Disease-Free and Overall Survival in Estrogen Receptor-Negative Breast Cancer |
| Q72610900 | Natural history of breast cancer |
| Q44197832 | Natural killer cell activities of patients with breast cancer against different target cells |
| Q41733205 | Near haploidy in breast cancer: a particular pathway of chromosome evolution |
| Q48578799 | Near-set Based Mucin Segmentation in Histopathology Images for Detecting Mucinous Carcinoma. |
| Q78128660 | Neoadjuvant chemotherapy in young breast cancer patients: correlation between response and relapse? |
| Q37638082 | Neoadjuvant chemotherapy with trastuzumab in HER2-positive breast cancer: pathologic complete response rate, predictive and prognostic factors. |
| Q44278902 | Neuroendocrine differentiation in carcinoma of the breast. Tyramide signal amplification discloses chromogranin A-positive tumour cells in more breast tumours than previously realized |
| Q21260387 | Neuropilin-2 expression in breast cancer: correlation with lymph node metastasis, poor prognosis, and regulation of CXCR4 expression |
| Q33940503 | New prognostic histological parameter of invasive ductal carcinoma of the breast: clinicopathological significance of fibrotic focus |
| Q70192356 | Nipple involvement and multicentricity in breast cancer. A study on whole organ sections |
| Q36614826 | No association of breast cancer risk with integrin beta3 (ITGB3) Leu33Pro genotype |
| Q35746956 | No significant association of Epstein-Barr virus infection with invasive breast carcinoma |
| Q44663767 | Nodal involvement in poorly differentiated breast cancer |
| Q70165089 | Normal epithelial antigens recognized by GB3 and GB5 are diminished in intraductal and lost in infiltrating human breast carcinomas |
| Q57742715 | Nuclear Localization of Cytokeratin 8 and the O-linkedN-Acetylglucosamine-containing Epitope H in Epithelial Cells of Infiltrating Ductal Breast Carcinomas: A Combination of Immunogold and EDTA Regressive Staining Methods |
| Q38483058 | Nuclear accumulation of p53 protein correlates with mutations in the p53 gene on archival paraffin-embedded tissues of human breast cancer |
| Q44646441 | Nuclear characteristics as indicators of prognosis in node negative breast cancer patients |
| Q71689171 | Nuclear grading and flow cytometric DNA pattern in fine-needle aspirates of primary breast cancer |
| Q36817844 | Nuclear image analysis of immunohistochemically stained cells in breast carcinomas |
| Q55282601 | Nuclear p53 Immunoreaction Associated with Poor Prognosis of Breast Cancer |
| Q35832474 | Nuclear p53 protein accumulates preferentially in medullary and high-grade ductal but rarely in lobular breast carcinomas |
| Q44633006 | Nuclear pleomorphism, a strong prognostic factor in axillary node-negative small invasive breast cancer |
| Q44188259 | Nuclear polymorphism--a prognostic parameter to evaluate local recurrence of female breast cancer |
| Q69357811 | Nucleolar grading of breast cancer. Comparative studies on frequency and localization of nucleoli and histology, stage, hormonal receptor status and lectin histochemistry |
| Q72760381 | Nucleolar organizer regions in myofibroblasts in breast cancer. Relation to cancer cell morphometry, flow cytometry, sex steroid receptor content, tumour histology and prognosis |
| Q72879000 | Nucleolar organizer regions related to morphometry, flow cytometry, sex steroid receptor content, tumour histology and prognosis in female breast cancer |
| Q35893447 | Nutritional channels in breast cancer |
| Q37222610 | Obesity and poor breast cancer prognosis: an illusion because of hormone replacement therapy? |
| Q44882523 | Occult metastases in axillary lymph nodes as a predictor of survival in node-negative breast carcinoma with long-term follow-up |
| Q36045809 | Oestrogen and progesterone cytosolic receptors in clinically inflammatory tumours of the human breast |
| Q64903575 | Oestrogen and progesterone receptor content and the distribution of histological grade in breast cancer. |
| Q36027980 | Oestrogen and progesterone receptor distribution in the cancerous breast |
| Q38489864 | Oestrogen receptor in breast cancer: prognostic studies using a new immunohistochemical assay |
| Q35749364 | Oestrogen receptor negative breast cancers exhibit high cytokine content |
| Q39739835 | Oestrogen receptor/progesterone receptor and human epidermal growth factor receptor 2 status in breast cancer: a 9-year study at Princess Noorah Oncology Center, Saudi Arabia |
| Q67240320 | Oestrogen receptors in human breast cancer. Problems of correlation with histopathological features |
| Q35830503 | Oncogene amplification in breast cancer |
| Q30493410 | Oncology |
| Q43721768 | Operable cancer of the breast.A controlled clinical trial |
| Q53633758 | Optical quantitative pathology of cervical intraepithelial neoplasia in human tissues using spatial frequency analysis. |
| Q46975849 | Optical redox imaging indices discriminate human breast cancer from normal tissues |
| Q52632722 | Optoacoustics delineates murine breast cancer models displaying angiogenesis and vascular mimicry. |
| Q53019539 | Oral contraceptive use and the prognosis of breast cancer. |
| Q37103673 | Outcome Disparities in African American Compared with European American Women with ER+HER2- Tumors Treated within an Equal-Access Health Care System |
| Q36624255 | Outcome after extended follow-up in a prospective study of operable breast cancer: key factors and a prognostic index |
| Q37564081 | Outcome disparities in African American women with triple negative breast cancer: a comparison of epidemiological and molecular factors between African American and Caucasian women with triple negative breast cancer |
| Q33875158 | Overexpression of BRCA2 gene in sporadic breast tumours. |
| Q35979202 | Overexpression of group II phospholipase A2 in human breast cancer tissues is closely associated with their malignant potency |
| Q36620762 | Overexpression of stathmin in breast carcinomas points out to highly proliferative tumours |
| Q36114982 | Overexpression of the stathmin gene in a subset of human breast cancer |
| Q30870747 | Overview of breast cancer collaborative stage data items--their definitions, quality, usage, and clinical implications: a review of SEER data for 2004-2010. |
| Q73880831 | P53 determination alongside classical prognostic factors in node-negative breast cancer: an evaluation at more than 10-year follow-up |
| Q40261157 | PIK3CA mutations in serum DNA are predictive of recurrence in primary breast cancer patients |
| Q60286467 | PIP/GCDFP-15 gene expression and apocrine differentiation in carcinomas of the breast |
| Q34227580 | PTK6/BRK is expressed in the normal mammary gland and activated at the plasma membrane in breast tumors |
| Q44748335 | Parallel evolution of tumour subclones mimics diversity between tumours |
| Q33648880 | Paraoxonase 1 gene polymorphisms are associated with an increased risk of breast cancer in a population of Chinese women |
| Q69569772 | Partial mastectomy: pathologic findings and prognosis |
| Q100954142 | Pathfinders in oncology from the first clinical use of single-agent chemotherapy to the introduction of mammography |
| Q47189605 | Pathologic analysis of tumor size and lymph node status in multifocal/multicentric breast carcinoma |
| Q70183793 | Pathologic predictors of early local recurrence in stage I and II breast cancer treated by primary radiation therapy |
| Q36815850 | Pathological features of invasive breast cancer associated with a high risk of local recurrence after tumour excision and radical radiotherapy |
| Q53461482 | Pathological prognostic factors in breast cancer. IV: Should you be a typer or a grader? A comparative study of two histological prognostic features in operable breast carcinoma. |
| Q76396088 | Pathology of breast carcinoma |
| Q43533936 | Patient's and doctor's delay in primary breast cancer. Prognostic implications |
| Q47300936 | Patients with recurrent breast cancer: does the primary axillary lymph node status predict more aggressive tumor progression? |
| Q73816218 | Pattern of dissemination and survival following isolated locoregional recurrence of breast cancer. A prospective study with more than 10 years of follow up |
| Q72731815 | Peanut lectin histochemistry of 120 mammary carcinomas and its relation to tumor type, grading, staging, and receptor status |
| Q44852814 | Peritumoral lymphatic vessel invasion compared with DNA ploidy, proliferative activity, and other pathologic features as prognostic indicators in operable breast cancer |
| Q30407002 | Photoacoustic image patterns of breast carcinoma and comparisons with Magnetic Resonance Imaging and vascular stained histopathology |
| Q24535558 | Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1. |
| Q66940551 | Plasma spermine concentrations of patients with benign and malignant tumours of the breast or prostate |
| Q57089523 | Plasminogen activator expression and steroid hormone receptors in female breast cancer: A multifactorial study |
| Q36430945 | Plasminogen activator inhibitor-1 (PAI-1) is not related to response to neoadjuvant chemotherapy in breast cancer |
| Q40124397 | Pleural effusion in breast cancer: a review of 105 cases |
| Q54333727 | Podoplanin expression by cancer-associated fibroblasts predicts poor outcome in invasive ductal breast carcinoma. |
| Q67789550 | Polyadenylic-polyuridylic acid plus locoregional and pelvic radiotherapy versus chemotherapy with CMF as adjuvants in operable breast cancer. A 6 1/2 year follow-up analysis of a randomized trial of the French Federation of Cancer Centers (F.F.C.C.) |
| Q73875584 | Polyamine profiles in tumor, normal tissue of the homologous breast, blood, and urine of breast cancer sufferers |
| Q54337988 | Polymorphic variant Ser128Arg of E-Selectin is associated with breast cancer risk and high grade tumors. |
| Q72452732 | Positron emission tomography and breast masses: comparison with clinical, mammographic, and pathological findings |
| Q40213711 | Possible Histologic Markers for Early and Late Stages of Breast Cancer |
| Q27009040 | Possible biological and translational significance of mast cells density in colorectal cancer |
| Q36038457 | Possible host resistance in carcinoma of the breast: a histological study |
| Q71028731 | Post-operative serum sialyltransferase levels and prognosis in breast cancer |
| Q33846562 | Postmastectomy locoregional recurrence and recurrence-free survival in breast cancer patients |
| Q77911483 | Postmastectomy radiotherapy: randomized trials |
| Q41725997 | Potential clinical relevance of uPA and PAI-1 levels in node-negative, postmenopausal breast cancer patients bearing histological grade II tumors with ER/PR expression, during an early follow-up |
| Q46117610 | Power Doppler breast ultrasound: association of vascularization and ER/c-erbB-2 co-expression in invasive breast carcinoma |
| Q40181977 | Practical breast carcinoma cell kinetics: review and update |
| Q46872940 | Precise correlation between MRI and histopathology – Exploring treatment margins for MRI-guided localized breast cancer therapy |
| Q52712527 | Predicting breast cancer recurrence. |
| Q37976086 | Predicting distant metastases in operable breast cancer patients |
| Q44682388 | Predicting multidrug resistance-related protein and P-glycoprotein expression with technetium-99m tetrofosmin mammoscintigraphy |
| Q72871989 | Predicting recurrence in axillary-node negative breast cancer patients |
| Q33785765 | Predicting the future: a critical appraisal of cancer prognosis studies |
| Q36694709 | Prediction of metastasis risk (11 year follow-up) using VEGF-R1, VEGF-R2, Tie-2/Tek and CD105 expression in breast cancer (n=905). |
| Q36293034 | Predictive value of topoisomerase IIalpha and other prognostic factors for epirubicin chemotherapy in advanced breast cancer |
| Q46784173 | Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer. |
| Q58781862 | Predictive value of tumor-infiltrating lymphocytes to pathological complete response in neoadjuvant treated triple-negative breast cancers |
| Q44187042 | Predictors of lymph node metastasis in T1 breast carcinoma, stratified by patient age. |
| Q40964424 | Predictors of recurrence for patients with small (one centimeter or less) localized breast cancer (T1a,b N0 M0). |
| Q44447430 | Pregnancy and breast cancer: a population-based study |
| Q73144800 | Premenopausal node-negative breast cancer: may adjuvant chemotherapy be indicated by the analysis of nuclear DNA dynamics? |
| Q53504737 | Premorphological metabolic changes in human breast carcinogenesis. |
| Q71861109 | Preoperative assessment of proliferative activity and hormonal receptor status in carcinoma of the breast: a comparison of needle aspiration and needle-core biopsies to the surgical specimen |
| Q80258834 | Preoperative selection of symptomatic breast cancer patients appropriate for lymphatic mapping and sentinel node biopsy |
| Q37195907 | Presence of epidermal growth factor receptor as an indicator of poor prognosis in patients with breast cancer |
| Q70595314 | Presurgical radiotherapy decreases the concentrations of estrogen and progesterone receptors in human breast cancer: a 200-patient study |
| Q36616299 | Primary tumour-vessel tumour-nodal tumour classification for patients with invasive ductal carcinoma of the breast |
| Q36575223 | Problems in histological grading of malignancy and its clinical significance in patients with operable breast cancer |
| Q35978056 | Production of immunoreactive polymorphonuclear leucocyte elastase in human breast cancer cells: possible role of polymorphonuclear leucocyte elastase in the progression of human breast cancer |
| Q33723331 | Profile of breast and gynecological cancers in Yaoundé--Cameroon |
| Q40590485 | Progesterone and Oestrogen Receptors in Human Breast Cancer |
| Q67539054 | Progesterone receptor determined by immunocytochemical and biochemical methods in human breast cancer |
| Q36079769 | Prognosis based on primary breast carcinoma instead of pathological nodal status |
| Q69052825 | Prognosis in node-negative breast cancer |
| Q45048537 | Prognosis of salivary adenocarcinomas. A retrospective study of 52 cases with special regard to cytochemically assessed nuclear DNA content |
| Q67058924 | Prognostic Relevance of Immunologic Variables in Breast Carcinoma |
| Q57278981 | Prognostic Significance of TGF-α Expression in Breast Cancer |
| Q34089296 | Prognostic and Predictive Factors for Breast Cancer |
| Q37614687 | Prognostic and predictive factors and genetic analysis of early breast cancer. |
| Q31950757 | Prognostic and predictive value of c-erbB-2 (HER-2/neu) gene amplification in human breast cancer |
| Q38484552 | Prognostic association of c-erbB-2 oncogene amplification and protein overexpression in human breast cancer using archival tissues. A comparative study |
| Q44942845 | Prognostic evaluation in node-positive breast carcinoma: stage versus growth rate |
| Q41007573 | Prognostic evaluation of oestrogen-regulated protein immunoreactivity in ductal invasive (NOS) breast cancer |
| Q72106502 | Prognostic factors from the fine-needle aspirate: breast carcinoma nuclear grade |
| Q37321930 | Prognostic factors in 1,038 women with metastatic breast cancer |
| Q67839931 | Prognostic factors in axillary lymph node-negative (pN−) breast carcinomas |
| Q34639820 | Prognostic factors in breast cancer: current and new predictors of metastasis |
| Q41739038 | Prognostic factors in invasive carcinoma of the breast |
| Q35982827 | Prognostic factors in recurrent breast cancer: relationships to site of recurrence, disease-free interval, female sex steroid receptors, ploidy and histological malignancy grading |
| Q48404872 | Prognostic factors of HER2-positive breast cancer patients who develop brain metastasis: a multicenter retrospective analysis |
| Q36421643 | Prognostic impact of proliferation-associated factors MIB1 (Ki-67) and S-phase in node-negative breast cancer |
| Q47928690 | Prognostic markers in breast cancer: the reliability of HER2/neu status in core needle biopsy of 325 patients with primary breast cancer |
| Q33576675 | Prognostic significance of TRAIL-R3 and CCR-2 expression in tumor epithelial cells of patients with early breast cancer. |
| Q73468817 | Prognostic significance of c-erbB-2/neu amplification and epidermal growth factor receptor (EGFR) in primary breast cancer and their relation to estradiol receptor (ER) status |
| Q74561747 | Prognostic significance of cell cycle parameters in infiltrative ductal breast carcinoma |
| Q36643694 | Prognostic significance of dihydropyrimidine dehydrogenase expression in breast cancer |
| Q44123907 | Prognostic significance of flow cytometric DNA analysis in node-negative breast cancer patients |
| Q38488717 | Prognostic significance of her-2/neu expression in breast cancer and its relationship to other prognostic factors |
| Q35721214 | Prognostic significance of immunoreactive neutrophil elastase in human breast cancer: long-term follow-up results in 313 patients |
| Q54291108 | Prognostic significance of oestrogen and progestogen receptor activities in breast cancer. |
| Q35992050 | Prognostic significance of peritumoral vascular invasion in breast cancer |
| Q69917980 | Prognostic significance of peritumoral vessel invasion in clinical trials of adjuvant therapy for breast cancer with axillary lymph node metastasis |
| Q44584694 | Prognostic significance of psychosocial factors in African-American and white breast cancer patients: a population-based study |
| Q38355301 | Prognostic significance of reduced expression of β‐N‐acetylgalactosaminylated N‐linked oligosaccharides in human breast cancer |
| Q93638402 | Prognostic significance of some pathologic factors in breast carcinoma |
| Q69025955 | Prognostic significance of steroid hormone receptors and histopathological characterization of human breast cancer |
| Q59647396 | Prognostic significance of the immunohistochemical reaction to human milk fat globule antibodies in node-negative and node-positive breast cancer |
| Q39747830 | Prognostic significance of tumor grade in clinical trials of adjuvant therapy for breast cancer with axillary lymph node metastasis |
| Q42072100 | Prognostic significance of tumor phosphatidylcholine stearic acid level in breast carcinoma. |
| Q36292147 | Prognostic significance of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in primary breast cancer. |
| Q47383020 | Prognostic studies in breast cancer. Multivariate combination of nodal status, proliferation index, tumor size, and DNA ploidy |
| Q93658294 | Prognostic typing in breast cancer |
| Q36653188 | Prognostic typing in breast cancer. Further investigation of a necropsy series compared with recent surgical specimens |
| Q35933318 | Prognostic value of ERBB4 expression in patients with triple negative breast cancer |
| Q36081445 | Prognostic value of bcl-2 expression in invasive breast cancer |
| Q70766848 | Prognostic value of breast cancer cytologic grading: a retrospective study of 213 cases |
| Q72674723 | Prognostic value of cytological grading of fine-needle aspirates from breast carcinomas |
| Q53465154 | Prognostic value of cytosolic thymidine kinase activity as a marker of proliferation in breast cancer. |
| Q71976300 | Prognostic value of epidermal growth factor expression in breast cancer |
| Q43989152 | Prognostic value of histological grading in noninflammatory canine mammary carcinomas in a prospective study with two-year follow-up: relationship with clinical and histological characteristics. |
| Q44199579 | Prognostic value of proliferating cell nuclear antigen and c-erbB-2 compared with conventional histopathological factors in breast cancer |
| Q36135327 | Prognostic value of steroid receptors after long-term follow-up of 2257 operable breast cancers |
| Q42389842 | Prognostic value of the S-phase fraction of breast cancer |
| Q53741237 | Prognostic value of the histopathologic private characteristics of breast cancer in patients with no axillary lymph node involvement. |
| Q71971446 | Prognostic value of total cathepsin B in invasive ductal carcinoma of the breast |
| Q43582753 | Prognostic value of total cathepsin D in breast tumors. A possible role in selection of chemoresistant patients |
| Q36617900 | Prognostic value of uPA and p53 accumulation measured by quantitative biochemical assays in 1245 primary breast cancer patients: a multicentre study. |
| Q36292537 | Prognostic value of urokinase plasminogen activator in primary breast carcinoma: comparison of two immunoassay methods |
| Q35977650 | Prognostic value of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in breast carcinomas |
| Q56638009 | Prognostische Faktoren beim duktalen Carcinoma in situ |
| Q35832637 | Proliferating cell nuclear antigen immunohistochemistry using monoclonal antibody 19A2 and a new antigen retrieval technique has prognostic impact in archival paraffin-embedded node-negative breast cancer. |
| Q72861106 | Proliferating cell nuclear antigen in breast carcinomas. An immunohistochemical study with correlation to histopathological features and prognostic factors |
| Q36741114 | Proliferating-cell nuclear antigen (PC10) immunolabelling and other proliferation indices as prognostic factors in breast cancer |
| Q28289007 | Proliferation is the strongest prognosticator in node-negative breast cancer: significance, error sources, alternatives and comparison with molecular prognostic markers |
| Q35639968 | Proliferative activity in primary breast carcinomas is a salient prognostic factor |
| Q35833969 | Proliferative activity is a significant prognostic factor in male breast carcinoma |
| Q44168562 | Proliferative activity of breast cancers increases in the course of genetic evolution as defined by cytogenetic analysis |
| Q51034997 | Promoter methylation and gene polymorphism are two independent events in regulation of GSTP1 gene expression. |
| Q44050955 | Proposal of a histopathological predictive rule for the differential diagnosis between American tegumentary leishmaniasis and sporotrichosis skin lesions |
| Q45823399 | Prospective cohort study of lifetime physical activity and breast cancer survival |
| Q36136220 | Prospective evaluation of prognostic factors in operable breast cancer |
| Q36255901 | Prospects of Targeting the Gastrin Releasing Peptide Receptor and Somatostatin Receptor 2 for Nuclear Imaging and Therapy in Metastatic Breast Cancer |
| Q35992238 | Prostaglandin F2 alpha in benign and malignant breast tumours |
| Q39454742 | Prostaglandins and breast cancer |
| Q46230212 | Psychosocial correlates of progesterone receptors in breast cancer |
| Q33838936 | Pure and mixed mucinous breast carcinomas: DNA stemline and prognosis |
| Q43848239 | Quantification of estrogen receptor alpha and beta expression in sporadic breast cancer. |
| Q43184186 | Quantification of metabolites in breast cancer patients with different clinical prognosis using HR MAS MR spectroscopy |
| Q33839395 | Quantitation of human milk fat globule (HMFG1) expression in breast carcinoma and its association with survival |
| Q24646799 | Quantitative analysis of human kallikrein gene 14 expression in breast tumours indicates association with poor prognosis |
| Q77128783 | Quantitative determination of c-erbB-2 in human breast tumours: potential prognostic significance of low values |
| Q68347230 | Quantitative determination of water-soluble scavengers in neoplastic and non-neoplastic human breast tissue |
| Q45074081 | Quantitative exploration of possible reasons for the recent improvement in breast cancer survival |
| Q39243708 | Quantitative features of chromatin structure in the prognosis of breast cancer |
| Q44454492 | Quantitative histopathology in ductal carcinoma of the breast. Prognostic value of mean nuclear size and mitotic counts. |
| Q71579629 | Quantitative histopathology in lymph node-negative breast cancer. Prognostic significance of mitotic counts |
| Q43601106 | Quantitative morphometric analysis of fine needle aspirates of breast carcinoma |
| Q55182367 | Quantitative nuclear histomorphometry predicts oncotype DX risk categories for early stage ER+ breast cancer. |
| Q33421127 | Quantitative real-time RT-PCR and chromogenic in situ hybridization: precise methods to detect HER-2 status in breast carcinoma |
| Q73665512 | Quantitative thresholds for mitotic counts in histologic grading: confirmation in nonfrozen samples of invasive ductal breast cancer |
| Q36793176 | ROS1 expression in invasive ductal carcinoma of the breast related to proliferation activity |
| Q34035440 | Radiation recall dermatitis with azithromycin |
| Q41071912 | Randomized Trial With Poly A-Poly U as Adjuvant Therapy Complementing Surgery in Patients With Breast Cancer: In Vitro Study of Cellular Immunity |
| Q46573303 | Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by Paclitaxel for early breast cancer. |
| Q73666678 | Randomized trial on the effect of radiotherapy in addition to 6 cycles CMF in node-positive breast-cancer patients. The German Breast-Cancer Study Group |
| Q43743504 | Rapid and prognostically valid quantification of immunohistochemical reactions by immunohistometry of the most positive tumour focus. A prospective follow-up study on breast cancer using antibodies against MIB-1, PCNA, ER, and PR. |
| Q44317862 | Real-time reverse transcription PCR assay of CYP19 expression: application to a well-defined series of post-menopausal breast carcinomas |
| Q35994335 | Rearrangement of chromosome 1p in breast cancer correlates with poor prognostic features |
| Q70196735 | Receptor heterogeneity of human breast cancer as measured by multiple intratumoral assays of estrogen and progesterone receptor |
| Q36037752 | Recording the gross outlines of breast tumours. A pathological assessment of the accuracy of radiographs of breast cancers |
| Q24300495 | Regulation of BRCC, a holoenzyme complex containing BRCA1 and BRCA2, by a signalosome-like subunit and its role in DNA repair |
| Q35747455 | Regulation of DCIS to invasive breast cancer progression by Singleminded-2s (SIM2s). |
| Q41474700 | Relation between receptor status and ultrastructure in breast cancer: E+P+ versus E-P-. |
| Q36888069 | Relation between socioeconomic deprivation and pathological prognostic factors in women with breast cancer |
| Q70458727 | Relation of elastosis to biochemical and immunohistochemical steroid receptor findings, Ki-67 and epidermal growth factor receptor (EGFR) immunostaining in invasive ductal breast cancer |
| Q44118465 | Relationship among outcome, stage of disease, and histologic grade for 22,616 cases of breast cancer. The basis for a prognostic index |
| Q44750877 | Relationship between epidermal growth factor receptor status and various prognostic factors in human breast cancer |
| Q36042804 | Relationship between oestrogen-receptor content and histological grade in human primary breast tumours |
| Q57618776 | Relationship between radioligand binding assay, immunoenzyme assay and immunohistochemical assay for estrogen receptors in human breast cancer and association with tumor differentiation |
| Q72960556 | Relationship between the content of estrogen and progesterone receptors and the pathological characteristics in human breast cancer |
| Q53554826 | Relationship between ultrastructure and receptor content of human primary breast cancer. |
| Q34285348 | Relationships between the ABO blood group SNP rs505922 and breast cancer phenotypes: a genotype-phenotype correlation study |
| Q67999775 | Relevance of DNA ploidy as a measure of genetic deviation: a comparison of flow cytometry and cytogenetics in 25 cases of human breast cancer |
| Q69484419 | Response to endocrine therapy and breast cancer differentiation |
| Q43540153 | Retinoid receptors in human breast carcinoma: possible modulators of in situ estrogen metabolism |
| Q36260072 | Ridle for sparse regression with mandatory covariates with application to the genetic assessment of histologic grades of breast cancer |
| Q44061807 | Risk factors for breast recurrence in premenopausal and postmenopausal patients with ductal cancers treated by conservation therapy |
| Q73311852 | Risk factors for local recurrence after conservative treatment in stage I breast cancer. Definition of a subgroup not requiring radiotherapy |
| Q24642091 | Role of WISP-2/CCN5 in the maintenance of a differentiated and noninvasive phenotype in human breast cancer cells |
| Q37536936 | Role of cyclin D1 in breast carcinoma |
| Q53298412 | Role of ethnic variations in TNF-α and TNF-β polymorphisms and risk of breast cancer in India. |
| Q32139894 | Role of lipids, lipoproteins and vitamins in women with breast cancer |
| Q43913944 | S-phase fraction and nuclear size in long term prognosis of patients with breast cancer |
| Q38441311 | S-phase fraction as an independent prognostic factor of long-term overall survival in patients with early-stage or locally advanced invasive breast carcinoma |
| Q38882282 | S100A14 is a novel independent prognostic biomarker in the triple-negative breast cancer subtype. |
| Q44939946 | SHP2 is up-regulated in breast cancer cells and in infiltrating ductal carcinoma of the breast, implying its involvement in breast oncogenesis |
| Q47557579 | Salivary Duct Carcinoma and Invasive Ductal Carcinoma of the Breast: A Comparative Immunohistochemical Study |
| Q49087189 | Screening for breast cancer in Ghent, Belgium: first results of a programme involving the existing health services |
| Q36575652 | Screening for breast cancer: current status, problems, prospects |
| Q71768125 | Sector mastectomy in selected cases of breast cancer |
| Q70818186 | Selection of high risk groups among prognostically favorable patients with breast cancer |
| Q33839752 | Semiquantitative analyses of fine needle aspirates from benign and malignant breast lesions |
| Q53721516 | Sequential assessment of multidrug resistance phenotype and measurement of S-phase fraction as predictive markers of breast cancer response to neoadjuvant chemotherapy. |
| Q40856336 | Sequential identification of factors predicting distant relapse in breast cancer patients treated by conservative surgery |
| Q34146042 | Serine protease PRSS23 is upregulated by estrogen receptor α and associated with proliferation of breast cancer cells |
| Q72008109 | Serological and immunohistochemical detection of a 65-kDa oncofetal protein in breast cancer |
| Q71784066 | Serum YKL-40: A new potential marker of prognosis and location of métastases of patients with recurrent breast cancer |
| Q71162660 | Serum levels of placental protein 10 (PP10) in women with breast cancer and genital carcinoma and in healthy male and female subjects |
| Q33984560 | Serum tryptase, mast cells positive to tryptase and microvascular density evaluation in early breast cancer patients: possible translational significance |
| Q44901494 | Serum-zinc and healing of venous leg ulcers |
| Q43651478 | Should all patients with node-negative breast cancer receive adjuvant therapy? Identifying additional subsets of low-risk patients who are highly curable by surgery alone |
| Q42876123 | Significance of Serum Tumor Necrosis Factor-Alpha and its Combination with Her-2 Codon 655 Polymorphism in the Diagnosis and Prognosis of Breast Cancer |
| Q28140971 | Significance of alpha 9 beta 1 and alpha v beta 6 integrin expression in breast carcinoma |
| Q33846216 | Significance of alpha-subunit HCG demonstrated in breast carcinomas by the immunoperoxidase technique |
| Q53986650 | Significance of the Tritiated Thymidine Labeling Index in breast cancers. |
| Q47992098 | Significant increase in breast conservation in 16 years of trials conducted by the Austrian Breast & Colorectal Cancer Study Group |
| Q93048654 | Significant inter- and intra-laboratory variation in grading of invasive breast cancer: A nationwide study of 33,043 patients in the Netherlands |
| Q31022986 | Similar NF-κB gene signatures in TNF-α treated human endothelial cells and breast tumor biopsies. |
| Q42163456 | Simple mastectomy with postoperative irradiation versus extended radical mastectomy in breast cancer. A twenty-five-year follow-up of a randomized trial |
| Q37111447 | Simplified method of grading primary carcinomas of the breast |
| Q36711468 | Simplified nuclear grading of fine-needle aspirates of breast carcinoma: concordance with corresponding histologic nuclear grading and flow cytometric data |
| Q70169545 | Sinus catarrh and histological grade in breast cancer |
| Q28481728 | Small molecule antagonists of the Wnt/β-catenin signaling pathway target breast tumor-initiating cells in a Her2/Neu mouse model of breast cancer |
| Q53882001 | Social and biological factors in relation to survival among black vs. white women with breast cancer. |
| Q53433923 | Somatic DNA alterations in breast carcinomas of different lymph-node status by DNA fingerprint analyses. |
| Q42438473 | Some characteristics of human cancer tissues in vitro |
| Q52310357 | Sonographic features of invasive ductal breast carcinomas predictive of malignancy grade. |
| Q31137005 | Spatial frequency analysis for detecting early stage of cancer in human cervical tissues |
| Q33914731 | Spatiotemporal progression of metastatic breast cancer: a Markov chain model highlighting the role of early metastatic sites. |
| Q91713420 | Sphingosine Kinase 1 in Breast Cancer-A New Molecular Marker and a Therapy Target |
| Q77435197 | Spontaneous programmed cell death in infiltrating duct carcinoma: association with p53, BCL-2, hormone receptors and tumor proliferation |
| Q36421707 | Squamoid features and expression of involucrin in primary breast carcinoma associated with high histological grade, tumour cell necrosis and recurrence sites |
| Q50577209 | Stage and survival in breast cancer patients in screened and non-screened Danish and Swedish populations. |
| Q35182925 | Staging system for breast cancer: revisions for the 6th edition of the AJCC Cancer Staging Manual |
| Q77053719 | Status of chromosome breaks and gaps in breast cancer. a follow-up study |
| Q77871599 | Stereologic evaluation of the vasculature in a MX1 xenotransplanted tumour model after combinations of treatment with ifosfamide, hyperthermia and irradiation |
| Q43778273 | Steroid receptor heterogeneity in relation to DNA index in breast cancer: a multiparameter flow cytometric approach on paraffin-embedded tumor samples |
| Q70175067 | Steroid receptors and prognosis in operable (stage I and II) breast cancer |
| Q71100418 | Steroid receptors in early breast cancer: Value in prognosis |
| Q73318922 | Stress-induced aberrant splicing of TSG101: association to high tumor grade and p53 status in breast cancers |
| Q70633279 | Stromal response in breast carcinoma and fibroadenomatosis, estimate by the aid of the alkaline phosphatase activity |
| Q69548197 | Studies concerning the regional lymph node in cancer. VI. Correlation of lymphocyte transformation of regional node cells and some histopathologic discriminants |
| Q33806008 | Studies of apoptosis in breast cancer |
| Q43495551 | Study of the relationship between immunohistologically demonstrated lymphocytes infiltrating human breast carcinomas and patients' survival |
| Q91920011 | Subtypes of Breast Cancer in Lao P.D.R.: A Study in a Limited-Resource Setting |
| Q35364435 | Survival after locoregional recurrence or second primary breast cancer: impact of the disease-free interval |
| Q37182133 | Survival in Norwegian BRCA1 mutation carriers with breast cancer |
| Q40080048 | Survival of patients with carcinoma of breast without lymph node metastases in relation to the tumor types |
| Q36596331 | Survival outcome of care by specialist surgeons in breast cancer: a study of 3786 patients in the west of Scotland |
| Q34440858 | Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial |
| Q51748628 | Synthesis of polydopamine as a new and biocompatible coating of magnetic nanoparticles for delivery of doxorubicin in mouse breast adenocarcinoma. |
| Q50994600 | Systematic analysis of breast cancer morphology uncovers stromal features associated with survival. |
| Q34576947 | Systemic adjuvant therapy for node-negative breast cancer |
| Q36127482 | THE INFLUENCE OF DELAY ON THE NATURAL HISTORY AND PROGNOSIS OF BREAST CANCER: A STUDY OF CASES FOLLOWED FOR FIVE TO TWENTY YEARS. |
| Q51255278 | THE INFLUENCE OF TUMOUR GRADE ON RADIOTHERAPY RESULTS. |
| Q50767432 | TOP2A and HER-2 gene amplification in fine needle aspirates from breast carcinomas. |
| Q37344716 | TP53 drives invasion through expression of its Δ133p53β variant |
| Q24529076 | TReP-132 controls cell proliferation by regulating the expression of the cyclin-dependent kinase inhibitors p21WAF1/Cip1 and p27Kip1 |
| Q60008045 | TYPE A (CORONARY PRONE) BEHAVIOUR IN DIABETICS |
| Q70158373 | Tamoxifen binding sites in human mammary cancers |
| Q50565674 | Tamoxifen in high-risk premenopausal women with primary breast cancer receiving adjuvant chemotherapy. Report from the Danish Breast Cancer co-operative Group DBCG 82B Trial. |
| Q34162501 | Targeting DNA replication before it starts: Cdc7 as a therapeutic target in p53-mutant breast cancers |
| Q38104568 | Taxane benefit in breast cancer--a role for grade and chromosomal stability |
| Q54646483 | Technique to obtain positron emission mammography images in registration with x-ray mammograms. |
| Q43849998 | Temporary dependency of steroid-receptor prognostic value in breast cancer |
| Q46444191 | Ten-year results comparing mastectomy to excision and radiation therapy for ductal carcinoma in situ of the breast |
| Q36115781 | Tenascin-C expression in invasion border of early breast cancer: a predictor of local and distant recurrence |
| Q35052176 | The B7-H1 (PD-L1) T lymphocyte-inhibitory molecule is expressed in breast cancer patients with infiltrating ductal carcinoma: correlation with important high-risk prognostic factors. |
| Q35923535 | The Continuing Challenge of Breast Cancer |
| Q69418061 | The DNA labelling index: a prognostic factor in node-negative breast cancer |
| Q91715241 | The Detection and Morphological Analysis of Circulating Tumor and Host Cells in Breast Cancer Xenograft Models |
| Q37451956 | The G protein-coupled estrogen receptor (GPER) is expressed in two different subcellular localizations reflecting distinct tumor properties in breast cancer |
| Q70167739 | The H-ras oncogene product p21 and prognosis in human breast cancer |
| Q26795717 | The INTRABEAM® Photon Radiotherapy System for the adjuvant treatment of early breast cancer: a systematic review and economic evaluation |
| Q46392750 | The Impact of Ki-67 on Immunostaining in Classification of Luminal Subtypes of breast Cancer |
| Q68250150 | The Impact of Nucleolar Organizer Regions for the Lymph Node Spread and Prognosis of Invasive Ductal Mammary Carcinoma |
| Q54338174 | The Japanese Breast Cancer Society Clinical Practice Guideline for pathological diagnosis of breast cancer. |
| Q40777892 | The Japanese Breast Cancer Society clinical practice guidelines for pathological diagnosis of breast cancer, 2015 edition |
| Q41054346 | The Nottingham Prognostic Index applied to 9,149 patients from the studies of the Danish Breast Cancer Cooperative Group (DBCG). |
| Q51041655 | The Prognostic Role of Mitotic Index in Hepatocellular Carcinoma Patients after Curative Hepatectomy. |
| Q42617736 | The Sample Type used Affects the Levels of Gelatinases (MMP-2 and -9) and their Inhibitors (TIMP-1 and -2) in Circulating Blood of Healthy Controls and Breast Cancer Patients |
| Q54687051 | The V109G polymorphism of the p27 gene CDKN1B indicates a worse outcome in node-negative breast cancer patients. |
| Q24646770 | The androgen-regulated gene human kallikrein 15 (KLK15) is an independent and favourable prognostic marker for breast cancer |
| Q36047743 | The association of cytosol oestrogen and progesterone receptors with histological features of breast cancer and early recurrence of disease |
| Q36466904 | The association of mammary serum antigen (MSA) with the histopathological findings in localised breast cancer |
| Q34125563 | The basic pathology of human breast cancer |
| Q30446768 | The biology of malignant breast tumors has an impact on the presentation in ultrasound: an analysis of 315 cases |
| Q36046479 | The cancer research campaign (King's/Cambridge trial for early breast cancer: clinico-pathological aspects |
| Q35082260 | The changing role of pathology in breast cancer diagnosis and treatment |
| Q38132239 | The classification of invasive carcinoma of the breast |
| Q36027636 | The clinical course of bone metastases from breast cancer |
| Q36047075 | The clinical value of immunohistochemically demonstrable CEA in breast cancer: a possible method of selecting patients for adjuvant chemotherapy. |
| Q37340485 | The combination of angiogenesis and blood vessel invasion as a prognostic indicator in primary breast cancer |
| Q71046399 | The cytochemical demonstration of oestrogen receptors in human breast carcinomas |
| Q40281837 | The demonstration of α lactalbumin in human breast carcinomas |
| Q67461178 | The detection and significance of calcifications in the breast: a radiological and pathological study |
| Q71548269 | The diagnostic cytology of breast carcinoma |
| Q30417120 | The differences in ultrasound and clinicopathological features between basal-like and normal-like subtypes of triple negative breast cancer |
| Q94671576 | The effect of an e-learning module on grading variation of (pre)malignant breast lesions |
| Q44543126 | The expression of DCC protein in female breast cancer. |
| Q58008706 | The expression of parathyroid hormone-related protein in human breast cancer with skeletal metastases |
| Q38644660 | The extracellular matrix in breast cancer predicts prognosis through composition, splicing, and crosslinking. |
| Q44187080 | The flow cytometric DNA index can predict the presence of lymph node metastases in invasive ductal breast carcinoma |
| Q44625909 | The functional relationship between in vivo bromodeoxyuridine labeling index and Ki-67 proliferation index in human breast cancer |
| Q52922984 | The grade of pancreatic ductal carcinoma is an independent prognostic factor and is superior to the immunohistochemical assessment of proliferation. |
| Q39866578 | The heparan sulfate sulfotransferase 3-OST3A (HS3ST3A) is a novel tumor regulator and a prognostic marker in breast cancer |
| Q40655540 | The histologic grading of cancer |
| Q40120607 | The histopathological evaluation of human breast cancers in correlation with estrogen receptor values |
| Q33390974 | The identification of ?casein? in human breast cancer |
| Q61857434 | The immunohistochemical expression of desmoplakin and its role in vivo in the progression and metastasis of breast cancer |
| Q36312142 | The impact of PTEN tumor suppressor gene on acquiring resistance to tamoxifen treatment in breast cancer patients |
| Q35225035 | The impact of matrix metalloproteinase 2 on prognosis and clinicopathology of breast cancer patients: a systematic meta-analysis |
| Q93668931 | The impact of morphological features on the prognosis of patients suffering from breast cancer |
| Q77741799 | The importance of surgery and accurate axillary staging for survival in breast cancer |
| Q71740242 | The important prognostic value of Ki-67 expression as determined by image analysis in breast cancer |
| Q72813510 | The influence of histological grading on prognosis in carcinoma of the tongue (a computer analysis of 299 cases) |
| Q69007503 | The influence of the wet-fixed Papanicolaou and the air-dried Giemsa techniques on nuclear parameters in breast cancer cytology: a cytomorphometric study |
| Q36618888 | The influence on survival of delay in the presentation and treatment of symptomatic breast cancer |
| Q37956452 | The invasive phenotypes |
| Q57573374 | The lectin-binding sites for peanut agglutinin in invasive breast ductal carcinomas and their role as a prognostic factor |
| Q67276224 | The localization of prolactin binding sites in human breast tissue |
| Q41613484 | The management of "early" breast cancer. A review of present philosophies |
| Q83291299 | The melanoma-associated antigen-A3, -A4 genes: relation to the risk and clinicopathological parameters in breast cancer patients |
| Q77333235 | The methodology of quantitation of microvessel density and prognostic value of neovascularization associated with long-term survival in Japanese patients with breast cancer |
| Q24309520 | The molecular mechanism governing the oncogenic potential of SOX2 in breast cancer |
| Q41389874 | The morphology of xenotransplanted human breast carcinoma MX-1 growing in nude mice. A light and transmission electron microscopic study |
| Q33186570 | The novel human MOST-1 (C8orf17) gene exhibits tissue specific expression, maps to chromosome 8q24.2, and is overexpressed/amplified in high grade cancers of the breast and prostate |
| Q44539653 | The nuclear BAG-1 isoform, BAG-1L, enhances oestrogen-dependent transcription. |
| Q48060921 | The nucleus is irreversibly shaped by motion of cell boundaries in cancer and non-cancer cells. |
| Q74459842 | The parathyroid hormone-related protein (PTHrP) gene: use of downstream TATA promotor and PTHrP 1-139 coding pathways in primary breast cancers vary with the occurrence of bone metastasis |
| Q39984158 | The pattern of spread and survival in 596 cases of breast cancer related to clinical staging and histological grade |
| Q62497458 | The predictive power of semiquantitative immunohistochemical assessment of p53 and c-erb B-2 in lymph node-negative breast cancer |
| Q43560476 | The presence of a fibrotic focus in invasive breast carcinoma correlates with the expression of carbonic anhydrase IX and is a marker of hypoxia and poor prognosis |
| Q72919566 | The prognostic effect of histological tumor grade in node-negative breast cancer patients |
| Q35954421 | The prognostic significance of determining DNA content in breast cancer by DNA image cytometry: the role of high grade aneuploidy in node negative breast cancer |
| Q43788104 | The prognostic significance of epidermal growth factor receptor expression in breast cancer |
| Q43838013 | The prognostic significance of ploidy analysis in operable breast cancer |
| Q71789821 | The prognostic value of c-erbB2 in primary breast carcinomas: A study on 942 cases |
| Q44481484 | The prognostic value of estrogen and progesterone receptors in female breast cancer. A single center study. |
| Q35992788 | The prognostic value of immunoperoxidase staining with monoclonal antibodies NCRC-11 and 3E1.2 in breast cancer. |
| Q43500323 | The prognostic value of oncogenic antigen 519 (OA-519) expression and proliferative activity detected by antibody MIB-1 in node-negative breast cancer. |
| Q41736712 | The prognostic value of proliferation indices: a study with in vivo bromodeoxyuridine and Ki-67. |
| Q34194117 | The prognostic value of the human kallikrein gene 9 (KLK9) in breast cancer. |
| Q73040960 | The prognostic value of the mitotic activity index in patients with primary breast cancer who were not treated with adjuvant systemic therapy |
| Q35992136 | The prognostic value of the monoclonal antibodies HMFG1 and HMFG2 in breast cancer |
| Q72432846 | The proliferating cell nuclear antigen index in breast carcinomas does not correlate with mitotic index and estrogen receptor immunoreactivity |
| Q44737518 | The relationship between growth fractions and oestrogen receptors in human breast carcinoma, as determined by immunohistochemical staining |
| Q36465911 | The relationship between histological grade, oestrogen receptor status, events and survival at 8 years in the NATO ('Nolvadex') trial |
| Q37193234 | The relationship between nuclear factor (NF)-κB family gene expression and prognosis in triple-negative breast cancer (TNBC) patients receiving adjuvant doxorubicin treatment |
| Q41627632 | The role of histologic grading in the prognosis of patients with carcinoma of the breast: is this a neglected opportunity? |
| Q41953341 | The role of nucleolar organiser regions as prognostic factors in breast cancer |
| Q37952743 | The role of the pathologist in breast cancer management |
| Q30399282 | The role of ultrasonographic findings to predict molecular subtype, histologic grade, and hormone receptor status of breast cancer |
| Q30372037 | The state of the art in breast imaging using the Twente Photoacoustic Mammoscope: results from 31 measurements on malignancies. |
| Q38394410 | The value of archival tissue blocks in understanding breast cancer biology |
| Q54167939 | The value of aspiration cytology in the diagnosis of breast cancer: Experience at the fondation curie |
| Q44450638 | The value of assessing cell proliferation in breast cancer |
| Q35838365 | The value of histology in the prognosis and classification of breast cancer |
| Q72234106 | Therapy of small breast cancer--four-year results of a prospective non-randomized study. German Breast Cancer Study Group (GBSG) |
| Q35831750 | Thrombospondin and other possible related matrix proteins in malignant and benign breast disease. An immunohistochemical study |
| Q59616929 | Thymidine labeling index and Ki-67 growth fraction in breast cancer: Comparison and correlation with prognosis |
| Q53404847 | Thymidine phosphorylase expression correlates with tumor differentiation and Bcl-2 in invasive breast cancer. |
| Q50574421 | Time trends and regional differences in registration, stage distribution, surgical management and survival of breast cancer in Denmark. |
| Q79821845 | Time-dependent effects on survival in breast carcinoma: results of 20 years of follow-up from the Swedish Two-County Study |
| Q46605823 | Tissue microarrays compared with whole sections and biochemical analyses. A subgroup analysis of DBCG 82 b&c. |
| Q46382077 | Tissue-type plasminogen activator (tPA) in breast cancer: relationship with clinicopathological parameters and prognostic significance |
| Q34405377 | Transcriptional regulation of hTREX84 in human cancer cells |
| Q42384301 | Transcripts for transforming growth factors in human breast cancer: clinical correlates |
| Q70155845 | Transferrin receptor (TrfR) expression in breast carcinoma and its possible relationship to prognosis. An immunohistochemical study |
| Q70093179 | Transferrin receptors in cultured breast cancer cells |
| Q38046516 | Translating mathematical modeling of tumor growth patterns into novel therapeutic approaches for breast cancer |
| Q26822823 | Translational implications of tumor heterogeneity |
| Q47863782 | Trastuzumab, non-pegylated liposomal-encapsulated doxorubicin and paclitaxel in the neoadjuvant setting of HER-2 positive breast cancer |
| Q26998991 | Treatment of Breast and Prostate Cancer by Hypofractionated Radiotherapy: Potential Risks and Benefits |
| Q57651530 | Treatment of Tumours of the Testis |
| Q62073063 | Treatment of breast carcinoma in patients with clinically negative axillary lymph nodes using radiotherapy versus axillary dissection |
| Q48614511 | Treatment outcomes and prognostic factors for patients with brain metastases from breast cancer of each subtype: a multicenter retrospective analysis |
| Q38397572 | Treatment response to preoperative anthracycline-based chemotherapy in locally advanced breast cancer: the relevance of proliferation and apoptosis rates |
| Q40125081 | Treatment results in mammary carcinoma stages I-IV. |
| Q33628415 | Trefoil factor 1 in early breast carcinoma: a potential indicator of clinical outcome during the first 3 years of follow-up |
| Q36288158 | Tumor architecture exerts no bias on nuclear grading in breast cancer diagnosis |
| Q37997681 | Tumor factors predicting for prognosis in metastatic breast cancer. The presence of P24 predicts for response to treatment and duration of survival |
| Q38190425 | Tumor factors predictive of response to hypofractionated radiotherapy in a randomized trial following breast conserving therapy |
| Q40809657 | Tumor flow in malignant breast tumors measured by Doppler ultrasound: an independent predictor of survival |
| Q60311169 | Tumor grade and molecular subtypes on local control in breast cancer radiotherapy: Does fractionation really matter? A retrospective control study group |
| Q72860001 | Tumor markers in patients with advanced breast cancer as prognosticators: a preliminary study |
| Q46595419 | Tumor microvascular characterization using ultrasmall superparamagnetic iron oxide particles (USPIO) in an experimental breast cancer model |
| Q34343963 | Tumor stromal vascular endothelial growth factor A is predictive of poor outcome in inflammatory breast cancer. |
| Q36027971 | Tumour aneuploidy, prognostic parameters and survival in primary breast cancer |
| Q70483073 | Tumour cyclic AMP binding proteins: an independent prognostic factor for disease recurrence and survival in breast cancer |
| Q77128847 | Tumour grade does not change between primary and recurrent mammary carcinoma |
| Q77529338 | Tumour grading and the one-year post-surgical prognosis in feline mammary carcinomas |
| Q35935349 | Tumour location within the breast: Does tumour site have prognostic ability? |
| Q82255361 | Twenty-five years of follow-up in patients with operable breast carcinoma: correlation between clinicopathologic factors and the risk of death in each 5-year period |
| Q70935382 | Typing and grading breast carcinoma on fine-needle aspiration: is this clinically useful information? |
| Q81396673 | Ultrasound morphology of invasive lobular breast cancer is different compared with other types of breast cancer |
| Q46535008 | Ultrastructural and immunohistochemical characteristics of lipid-rich carcinoma of the breast |
| Q73369593 | Urinary steroids at time of surgery in postmenopausal women with breast cancer |
| Q77162228 | Urokinase plasminogen activator is localized in stromal cells in ductal breast cancer |
| Q52881905 | Use of the mitotic counts for the prognosis and grading of breast cancer. Method evaluation study. |
| Q57688833 | Utilidad de la cuantificación de la captación de 99mTc-MIBI en neoplasias mamarias en la valoración preoperatoria de la agresividad tumoral |
| Q36046256 | Utilizing prognostic and predictive factors in breast cancer |
| Q73313966 | Validation of existing and development of new prognostic classification schemes in node negative breast cancer. German Breast Cancer Study Group |
| Q37207471 | Value of cytoprognostic classification in breast carcinomas |
| Q35994620 | Value of epidermal growth factor receptor status compared with growth fraction and other factors for prognosis in early breast cancer |
| Q44542715 | Variations in the mRNA expression of poly(ADP-ribose) polymerases, poly(ADP-ribose) glycohydrolase and ADP-ribosylhydrolase 3 in breast tumors and impact on clinical outcome. |
| Q54618189 | Vascular characterisation of triple negative breast carcinomas using dynamic MRI. |
| Q36621044 | Vascular grading of angiogenesis: prognostic significance in breast cancer. |
| Q59616913 | Very low-dose adjuvant chemotherapy in steroid receptor negative stage I breast cancer patients |
| Q36466249 | Vimentin and p53 expression on epidermal growth factor receptor-positive, oestrogen receptor-negative breast carcinomas |
| Q35812156 | Vimentin expression appears to be associated with poor prognosis in node-negative ductal NOS breast carcinomas |
| Q70465922 | Vimentin expression in 98 breast cancers with medullary features and its prognostic significance |
| Q37234527 | Vimentin expression in benign and malignant breast epithelium |
| Q38477486 | Vimentin expression is not associated with poor prognosis in breast cancer |
| Q35811970 | Vimentin is preferentially expressed in high-grade ductal and medullary, but not in lobular breast carcinomas |
| Q35811376 | Vimentin is preferentially expressed in human breast carcinomas with low estrogen receptor and high Ki-67 growth fraction |
| Q36467816 | West Midlands Oncology Association trials of adjuvant chemotherapy in operable breast cancer: results after a median follow-up of 7 years. I. Patients with involved axillary lymph nodes |
| Q36467888 | West Midlands Oncology Association trials of adjuvant chemotherapy in operable breast cancer: results after a median follow-up of 7 years. II. Patients without involved axillary lymph nodes. |
| Q35044222 | What is the Japanese consensus on adjuvant chemotherapy in breast cancer? |
| Q35395211 | What modifies the relation between tumour size and lymph node metastases in T1 breast carcinomas? |
| Q34558263 | What the clinician needs from the pathologist: evidence-based reporting in breast cancer |
| Q34553424 | Which patients are cured of breast cancer? |
| Q35852227 | X-RAY DIAGNOSIS OF DISEASES OF THE BREAST. STRUCTURE AND PATHOLOGY OF THE BREAST IN RELATION TO MAMMOGRAPHY |
| Q69771307 | [Cell cycle and catamnesis in breast cancer. Cytophotometric studies] |
| Q53075565 | [Histological grading of breast cancer]. |
| Q53606350 | [Improvement of breast cancer grading in punch biopsies: grading with the Ki-67 marker]. |
| Q69731952 | [Morphologic criteria in breast-saving surgery] |
| Q71110781 | [Tumorgrading in breast cancer by light microscopic and electron microscopic criteria. Part I. Relation between light microscopic grading and electron microscopic criteria. (author's transl)] |
| Q36080086 | alpha-Linolenic acid content of adipose breast tissue: a host determinant of the risk of early metastasis in breast cancer. |
| Q72254120 | bcl-2 protein in invasive ductal breast carcinomas |
| Q53363660 | c-erbB-2 expression and nuclear pleomorphism in canine mammary tumors. |
| Q38478519 | c-erbB-2 expression in FNAB smears and matched surgical specimens of breast cancer |
| Q35983237 | c-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes |
| Q72672964 | c-erbB-3 and c-erbB-2 protein expression in node-negative breast carcinoma--an immunocytochemical study |
| Q68084503 | c-erbB2 expression in correlation to other biological parameters of breast cancer |
| Q36027112 | gamma-Glutamyltranspeptidase activity in human breast lesions: an unfavourable prognostic sign |
| Q44840763 | p34cdc2 in invasive breast cancer: relationship to DNA content, Ki67 index and c-erbB-2 expression |
| Q36081235 | p53 as a prognostic factor in stage I breast cancer. South-East Sweden Breast Cancer Group |
| Q43140272 | p53 expression in tumor-stromal fibroblasts forming and not forming fibrotic foci in invasive ductal carcinoma of the breast |
| Q73594944 | p53 gene mutations and expression of p53 and mdm2 proteins in invasive breast carcinoma. A comparative analysis with clinico-pathological factors |
| Q47323884 | p53 inactivation is a rare event in familial breast tumors negative for BRCA1 and BRCA2 mutations. |
| Q35029530 | p53 mutant breast cancer patients expressing p53γ have as good a prognosis as wild-type p53 breast cancer patients. |
| Q33723628 | p53 mutation, deprivation and poor prognosis in primary breast cancer |
| Q55235050 | p53 mutations and c-erbB-2 amplification in intraductal and invasive breast carcinomas of high histologic grade. |
| Q73676170 | p53 mutations in BRCA1-associated familial breast cancer |
| Q43622908 | p53 protein expression and oestrogen and progesterone receptor status in invasive ductal breast carcinomas |
| Q73144803 | p53 protein expression in ductal carcinoma in situ (DCIS) of the breast |
| Q70840645 | p53 protein expression in fine-needle aspirates of breast cancer: an immunocytochemical assay for identifying high-grade ductal carcinomas |
| Q59616917 | p53 protein expression, cell proliferation and steroid hormone receptors in ductal and lobular in situ carcinomas of the breast |
| Q42485624 | p63 correlates with both BRCA1 and cytokeratin 5 in invasive breast carcinomas: further evidence for the pathogenesis of the basal phenotype of breast cancer. |
| Q35977596 | pS2 and response to adjuvant hormone therapy in primary breast cancer |
| Q70326043 | β2-Microglobulin in non-malignant and malignant human breast: A feature of differentiation |
Search more.